<SEC-DOCUMENT>0000919574-19-004362.txt : 20190701
<SEC-HEADER>0000919574-19-004362.hdr.sgml : 20190701
<ACCEPTANCE-DATETIME>20190628180440
ACCESSION NUMBER:		0000919574-19-004362
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20190701
DATE AS OF CHANGE:		20190628

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Castor Maritime Inc.
		CENTRAL INDEX KEY:			0001720161
		STANDARD INDUSTRIAL CLASSIFICATION:	DEEP SEA FOREIGN TRANSPORTATION OF FREIGHT [4412]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			1T
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-232052
		FILM NUMBER:		19930725

	BUSINESS ADDRESS:	
		STREET 1:		CHRISTODOULOU CHATZIPAVLOU 223
		STREET 2:		HAWAII ROYAL GARDENS, APART. 16
		CITY:			LIMASSOL
		STATE:			G4
		ZIP:			3036
		BUSINESS PHONE:		357 25357767

	MAIL ADDRESS:	
		STREET 1:		CHRISTODOULOU CHATZIPAVLOU 223
		STREET 2:		HAWAII ROYAL GARDENS, APART. 16
		CITY:			LIMASSOL
		STATE:			G4
		ZIP:			3036
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>d8312591_424b-5.htm
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: S&K
         Document created using EDGARfilings PROfile 6.0.0.0
         Copyright 1995 - 2019 Broadridge -->
  </head>
<body text="#000000" bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
  <div style="text-align: left;"><br>
  </div>
  <div style="text-align: left;">
    <div style="text-align: right; font-weight: bold;"><font style="background-color: #FFFFFF;">Filed Pursuant to Rule 424(b)(5)</font><br>
      <font style="background-color: #FFFFFF;">Registration No. 333-232052</font></div>
    <div><br>
    </div>
    <div style="font-weight: bold;">PROSPECTUS SUPPLEMENT</div>
    <div>(To Prospectus dated June 21, 2019)</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">$2,850,000</div>
    <div style="text-align: center; font-weight: bold;">Common Shares</div>
    <div><br>
    </div>
    <div style="text-align: center;"><img width="273" height="165" src="image00003.jpg"></div>
    <div><br>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">CASTOR MARITIME INC.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">This prospectus supplement relates to the issuance and sale of our common shares, par value $0.001 per share, having an aggregate offering price of up to $2,850,000, from time to
      time solely through Maxim Group LLC ("Maxim"), to whom we refer as the sales agent. Each common share sold in this offering includes a preferred stock purchase right that trades with the common share. These sales, if any, will be made pursuant to the
      terms of an equity distribution agreement between us and the sales agent, dated June 28, 2019.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Our common shares are traded on the Nasdaq Capital Market under the symbol "CTRM".&#160; On June 27, 2019, the last reported sales price of our common shares on the Nasdaq Capital
      Market was $4.19.&#160; As of the date hereof, we have not sold any securities pursuant to General Instruction I.B.5 of Form F-3 during the twelve calendar month period that ends on and includes the date of this prospectus supplement. The aggregate market
      value of our common shares held by non-affiliates pursuant to General Instruction I.B.5 of Form F-3 is $2,862,282, which was calculated based on 1,275,906 of our common shares outstanding and held by non-affiliates as of the date of this prospectus
      supplement and a price of $6.73 per share, the closing price of our common shares on April 29, 2019. As a result, we are currently eligible to offer and sell up to an aggregate of $2,862,282 of our common shares pursuant to General Instruction I.B.5
      of Form F-3.&#160; Should we be eligible and desire to offer additional common shares pursuant to the equity distribution agreement with Maxim, we will file an additional prospectus supplement to register the additional common shares and associated
      preferred stock purchase rights.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Sales of common shares, if any, under this prospectus supplement and the accompanying prospectus, may be made by means of ordinary brokers' transactions on the Nasdaq Capital
      Market, in negotiated transactions or transactions that are deemed to be "at the market" offerings as defined in Rule 415 under the Securities Act of 1933, as amended (the "Securities Act"), including sales made to or through a market maker other
      than on an exchange, at prices related to the prevailing market prices or at negotiated prices.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-weight: bold;">Investing in our common shares is speculative and involves significant risks. See "Risk Factors" beginning on page S-4 of this prospectus supplement, as well
      as the accompanying prospectus and the documents we have filed with the Securities and Exchange Commission that are incorporated by reference herein for more information, before you make any investment in our common shares.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-weight: bold;">None of the Securities and Exchange Commission, any state securities commission, or any other regulatory body has approved or disapproved of these securities
      or passed on the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The compensation to the sales agent for sales of common shares will be 3% of the gross sales price of all common shares sold through the sales agent from time to time under the
      equity distribution agreement. Subject to the terms and conditions of the equity distribution agreement, Maxim will use its commercially reasonable efforts to sell on our behalf any common shares to be offered by us under the equity distribution
      agreement. The net proceeds from any sales under this prospectus supplement will be used as described under "Use of Proceeds" in this prospectus supplement.</div>
    <div style="text-align: center; font-weight: bold; font-size: 20pt;">Maxim Group LLC</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">The date of this prospectus supplement is June 28, 2019</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%LCR%1%%%-->
    <div style="text-align: center; font-weight: bold;">TABLE OF CONTENTS</div>
    <div><br>
    </div>
    <div style="text-align: right; font-weight: bold;">Page</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">PROSPECTUS SUPPLEMENT</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z5b39b5d925aa438da409fe678d8d9bf9">

        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>IMPORTANT NOTICE ABOUT INFORMATION IN THIS PROSPECTUS SUPPLEMENT</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">s-i</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">s-ii</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>PROSPECTUS SUPPLEMENT SUMMARY</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">s-1</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>THE OFFERING</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">s-2</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>RISK FACTORS</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">s-3</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>USE OF PROCEEDS</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">s-6</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>CAPITALIZATION</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">s-7</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>SHARE HISTORY AND MARKETS</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">s-8</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;" rowspan="1">TAX CONSIDERATIONS <br>
          </td>
          <td style="width: 9.59%; vertical-align: top; text-align: right;" rowspan="1">s-9 <br>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>PLAN OF DISTRIBUTION</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">s-10</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">s-11</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">s-12</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>LEGAL MATTERS</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">s-12</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>WHERE YOU CAN FIND ADDITIONAL INFORMATION</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">s-12</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; margin-top: 12pt; font-weight: bold;">BASE PROSPECTUS</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z4a50f7d2d824477c8903bb10c4b5c10e">

        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">2</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>PROSPECTUS SUMMARY</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">4</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>RISK FACTORS</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">5</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>SHARE HISTORY AND MARKETS</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">6</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>USE OF PROCEEDS</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">7</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>CAPITALIZATION</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">8</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>ENFORCEMENT OF CIVIL LIABILITIES</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">9</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>PLAN OF DISTRIBUTION</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">10</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>DESCRIPTION OF SHARE CAPITAL</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">12</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>DESCRIPTION OF DEBT SECURITIES</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">19</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>DESCRIPTION OF WARRANTS</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">25</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>DESCRIPTION OF PURCHASE CONTRACTS</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">26</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>DESCRIPTION OF RIGHTS</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">27</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>DESCRIPTION OF UNITS</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">28</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>EXPENSES</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">29</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>LEGAL MATTERS</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">29</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>EXPERTS</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">29</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90.41%; vertical-align: top;">
            <div>WHERE YOU CAN FIND ADDITIONAL INFORMATION</div>
          </td>
          <td style="width: 9.59%; vertical-align: top;">
            <div style="text-align: right;">29</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">i</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%LCR%1%s-%%-->
    <div><br>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">IMPORTANT NOTICE ABOUT INFORMATION IN THIS PROSPECTUS SUPPLEMENT</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">This document is in two parts. The first part is this prospectus supplement, which describes the specific terms of this offering and also adds to and updates information
      contained in the accompanying base prospectus and the documents incorporated by reference into this prospectus supplement and the base prospectus. The second part, the base prospectus, gives more general information about securities we may offer from
      time to time, some of which does not apply to this offering. Generally, when we refer only to the prospectus, we are referring to both parts combined, and when we refer to the accompanying prospectus, we are referring to the base prospectus.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">If the description of this offering varies between this prospectus supplement and the accompanying prospectus, you should rely on the information in this prospectus supplement.
      This prospectus supplement, the accompanying prospectus and the documents incorporated into each by reference include important information about us, our common shares being offered and other information you should know before investing. You should
      read this prospectus supplement and the accompanying prospectus together with the additional information described under the heading "Where You Can Find More Information" before investing in our common shares.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Unless otherwise indicated, all references to "dollars" and "$" in this prospectus supplement are to, and amounts presented in, United States dollars and financial information
      presented in this prospectus supplement that is derived from financial statements incorporated by reference is prepared in accordance with accounting principles generally accepted in the United States.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We have authorized only the information contained or incorporated by reference in this prospectus supplement, the accompanying prospectus, and any free writing prospectus
      prepared by or on behalf of us or to which we have referred you. We have not, and any sales agents have not, authorized anyone to provide you with information that is different. We and the sales agent take no responsibility for, and can provide no
      assurance as to the reliability of, any information that others may give you. We are offering to sell, and seeking offers to buy, our common shares only in jurisdictions where offers and sales are permitted. The information contained in or
      incorporated by reference in this document is accurate only as of the date such information was issued, regardless of the time of delivery of this prospectus supplement or the date of any sale of our common shares.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">s-i</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin-bottom: 12pt;"><br>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">This prospectus supplement and the accompanying prospectus, including the information we incorporate by reference, include "forward-looking statements," as defined by U.S.
      federal securities laws, with respect to our financial condition, results of operations and business and our expectations or beliefs concerning future events. Words such as, but not limited to, "believe," "expect," "anticipate," "estimate," "intend,"
      "plan," "targets," "projects," "likely," "will," "would," "could" and similar expressions or phrases may identify forward-looking statements.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">All forward-looking statements involve risks and uncertainties. The occurrence of the events described, and the achievement of the expected results, depend on many events, some
      or all of which are not predictable or within our control. Actual results may differ materially from expected results.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">In addition, important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include: (i) our future
      operating or financial results; (ii) future, pending or recent acquisitions, joint ventures, business strategy, areas of possible expansion, and expected capital spending or operating expenses; (iii) drybulk shipping industry trends, including
      charter rates and factors affecting vessel supply and demand; (iv) our financial condition and liquidity, including our ability to obtain financing in the future to fund capital expenditures, acquisitions and other general corporate activities; (v)
      availability of crew, number of off-hire days, drydocking requirements and insurance costs; (vi) our expectations about the availability of vessels to purchase or the useful life of our vessel; (vii) our expectations relating to dividend payments and
      our ability to make such payments; (viii) our ability to leverage to our advantage our manager's relationships and reputations in the drybulk shipping industry; (ix) changes in seaborne and other transportation patterns; (x) changes in governmental
      rules and regulations or actions taken by regulatory authorities; (xi) potential liability from future litigation; (xii) global and regional political conditions; (xiii) acts of terrorism and other hostilities, including piracy; and (xiv) other
      important factors described from time to time in the reports filed by us with the Securities and Exchange Commission, which we refer to as the Commission or the SEC.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We have based these statements on assumptions and analyses formed by applying our experience and perception of historical trends, current conditions, expected future developments
      and other factors we believe are appropriate in the circumstances. All future written and verbal forward-looking statements attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements
      contained or referred to in this section. We undertake no obligation, and specifically decline any obligation, except as required by law, to publicly update or revise any forward-looking statements, whether as a result of new information, future
      events or otherwise. In light of these risks, uncertainties and assumptions, the forward-looking events discussed in this prospectus supplement might not occur.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">See the section entitled "Risk Factors," on page S-4 of this prospectus supplement, on page 6 of the accompanying prospectus and in our Annual Report on Form 20-F for the fiscal
      year ended September 30, 2018, filed with the SEC on January 31, 2019, and incorporated by reference herein, for a more complete discussion of these risks and uncertainties and for other risks and uncertainties. These factors and the other risk
      factors described in this prospectus supplement, the accompanying prospectus and the documents incorporated by reference are not necessarily all of the important factors that could cause actual results or developments to differ materially from those
      expressed in any of our forward-looking statements. Other unknown or unpredictable factors also could harm our results. Consequently, there can be no assurance that actual results or developments anticipated by us will be realized or, even if
      substantially realized, that they will have the expected consequences to, or effects on, us. Given these uncertainties, prospective investors are cautioned not to place undue reliance on such forward-looking statements.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">s-ii</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%s-%%-->
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">PROSPECTUS SUPPLEMENT SUMMARY</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-style: italic;">This summary provides an overview of our company and our business. This summary is not complete and does not contain all of the information you should
      consider before purchasing our securities. You should carefully read all of the information contained or incorporated by reference in this prospectus supplement and any accompanying prospectus, including the "Risk Factors" and our consolidated
      financial statements and related notes contained herein and therein, before making an investment decision. Unless we specify otherwise, all references in this prospectus to "we," "our," "us," "Castor" and the "Company" refer to Castor Maritime Inc.
      We use the term deadweight, or "dwt," in describing the size of our Vessel. Dwt, expressed in metric tons each of which is equivalent to 1,000 kilograms, refers to the maximum weight of cargo and supplies that a vessel can carry.</div>
    <div style="margin-bottom: 12pt; font-weight: bold;">Our Company</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We are a growth-oriented global shipping company engaged in the seaborne transportation of a wide range of dry bulk commodities including, among others, iron ore, coal and grain,
      collectively referred to as "major bulks," and steel products, fertilizers, cement, bauxite, sugar and scrap metal, collectively referred to as "minor bulks". We were incorporated in the Republic of the Marshall Islands on September 11, 2017.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">On September 22, 2017, we entered into an all-share exchange transaction (the "Magic P Purchase Transaction") pursuant to which we acquired 100% of the issued and outstanding
      capital stock of our sole wholly-owned subsidiary Spetses Shipping Co. ("Spetses"), a Marshall Islands corporation which owns a 76,453 dwt drybulk carrier, the Magic P, or our Vessel. The consideration for the Magic P Purchase transaction involved
      our issuance of 2,400,000 common shares, 480,000 9.75% Series A Cumulative Redeemable Perpetual Preferred Shares (the "Series A Preferred Shares") and 12,000 non-interest bearing Series B Preferred Shares (the "Series B Preferred Shares") to the then
      existing shareholders of Spetses.</div>
    <div style="margin-bottom: 12pt; font-weight: bold;">Our Fleet</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Our Fleet is currently comprised of our Vessel. The following table summarizes key information about our Vessel as of the date of this prospectus:</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z4b15ae2e086c40c6a8b6dcd76b76b279">

        <tr>
          <td style="width: 11.46%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; font-weight: bold;">Vessel Name</div>
          </td>
          <td style="width: 9.55%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; font-weight: bold;">Year Built</div>
          </td>
          <td style="width: 15.26%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; font-weight: bold;">Type of<br>
              Charter</div>
          </td>
          <td style="width: 11.32%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; font-weight: bold;">Capacity<br>
              (dwt)</div>
          </td>
          <td style="width: 17.79%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; font-weight: bold;">Delivered to Castor</div>
          </td>
          <td style="width: 14.42%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; font-weight: bold;">Earliest Charter Expiration</div>
          </td>
          <td style="width: 20.19%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; font-weight: bold;">Latest Charter Expiration</div>
          </td>
        </tr>
        <tr>
          <td style="width: 11.46%; vertical-align: top;">&#160;</td>
          <td style="width: 9.55%; vertical-align: top;">&#160;</td>
          <td style="width: 15.26%; vertical-align: top;">&#160;</td>
          <td style="width: 11.32%; vertical-align: top;">&#160;</td>
          <td style="width: 17.79%; vertical-align: top;">&#160;</td>
          <td style="width: 14.42%; vertical-align: top;">&#160;</td>
          <td style="width: 20.19%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 11.46%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="font-style: italic;">Magic P</div>
          </td>
          <td style="width: 9.55%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>2004</div>
          </td>
          <td style="width: 15.26%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Time Charter</div>
          </td>
          <td style="width: 11.32%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>76,453</div>
          </td>
          <td style="width: 17.79%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>September 2017</div>
          </td>
          <td style="width: 14.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>August 2019</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>November 2019 <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
          </td>
        </tr>

    </table>
    <div style="background-color: #FFFFFF;">
      <div><br>
      </div>
    </div>
    <div style="background-color: #FFFFFF;">
      <div><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" id="TRGRRTFtoHTMLTab">&#160;</font>On March 12, 2019, the Magic P commenced employment under a time charter with Oldendorff Carriers GMBH &amp; Co KG
        Luebeck&#160;at a gross charter rate of $11,250 per day (excluding the first 30-day period during which the daily gross rate was $9,000 per day). This charter has a minimum term of five (5) months, up to a maximum term of eight (8) months (plus or minus
        15 days).</div>
      <div><br>
      </div>
    </div>
    <div style="margin-bottom: 12pt; font-weight: bold;">Ship Management</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The ship management of our Vessel is provided by Pavimar, a company controlled by Ismini Panagiotidis, the sister of our Chairman, Chief Executive Officer and Chief Financial
      Officer, Petros Panagiotidis. Under the management agreement, Pavimar provides us with a wide range of shipping services such as crew management, technical management, operational employment management, insurance arrangements, provisioning,
      bunkering, accounting services, general administration and audit support.&#160; From December 16, 2017 and for a period of two years afterward, the fixed daily management fee of our Vessel is $320, at which time the daily management fee may be revised.</div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">Corporate Information</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We were incorporated in the Republic of the Marshall Islands on September 11, 2017, with principal executive offices located at Christodoulou Chatzipavlou 223, Hawaii Royal
      Gardens, Apart. 16, 3036 Limassol, Cyprus. Our telephone number at that address is 011 (357) 25 357 7677. We maintain a website at http://www.castormaritime.com. Information contained on our website does not constitute part of this prospectus. Our
      fiscal year end date is September 30.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">s-1</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin-bottom: 10pt;"><br>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">THE OFFERING</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z02338ac6fc954a38acda43fbb9d11809">

        <tr>
          <td style="width: 39.84%; vertical-align: top;">
            <div>Common shares offered by us</div>
          </td>
          <td style="width: 60.16%; vertical-align: top;">
            <div>Common shares with an aggregate offering price of up to $2,850,000 or 680,191 common shares at an assumed offering price of $4.19, which was the last reported closing price of our common shares on June 27, 2019.</div>
            <div> <br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 39.84%; vertical-align: top;">
            <div>Common shares outstanding prior to this offering</div>
          </td>
          <td style="width: 60.16%; vertical-align: top;">
            <div>2,400,000 common shares.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
            <div> <br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 39.84%; vertical-align: top;">
            <div>Preferred Share Purchase Rights</div>
          </td>
          <td style="width: 60.16%; vertical-align: top;">
            <div>Our common shares include preferred share purchase rights, as described in the section of the accompanying prospectus entitled "Description of Capital Stock&#8212;Stockholders Rights Agreement."</div>
            <div> <br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 39.84%; vertical-align: top;"> Listing<br>
          </td>
          <td style="width: 60.16%; vertical-align: top;">
            <div>
              <div>Our common shares are traded on the Nasdaq Capital Market under the symbol &#8220;CTRM.&#8221; And the Norwegian OTC under the symbol &#8220;CASTOR.&#8221;</div>
            </div>
            <div> <br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 39.84%; vertical-align: top;">
            <div>Manner of offering</div>
          </td>
          <td style="width: 60.16%; vertical-align: top;">
            <div>Negotiated transactions or transactions deemed to be "at-the-market offerings" (including sales made to or through a market maker other than on an exchange) that may be made from time to time through Maxim, as sales agent, using
              commercially reasonable efforts. See "Plan of Distribution."</div>
            <div> <br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 39.84%; vertical-align: top;">
            <div>Use of Proceeds</div>
          </td>
          <td style="width: 60.16%; vertical-align: top;">
            <div>The net proceeds of this offering will be used to opportunistically fund growth opportunities, which may include the purchase of vessels, general corporate purposes or a combination thereof. As of the date hereof, we have not identified a
              potential target vessel to acquire. We may also use the proceeds to fund our general working capital requirements.<br>
              <br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 39.84%; vertical-align: top;">
            <div>Risk Factors</div>
          </td>
          <td style="width: 60.16%; vertical-align: top;">
            <div><font style="font-weight: bold;">Investing in our common shares is speculative and involves substantial risk. </font>You should carefully consider all the information in this prospectus supplement, the accompanying prospectus and the
              documents incorporated herein by reference prior to investing in our common shares. In particular, we urge you to consider carefully the factors set forth in the section entitled "Risk Factors" beginning on page S-4 of this prospectus
              supplement, as well as the accompanying prospectus and the documents we have filed with the SEC that are incorporated by reference herein for more information, before you make any investment in our common shares.</div>
          </td>
        </tr>

    </table>
    <div> <br>
      _____________<br>
    </div>
    <div><font style="font-size: 8pt;">(1) Under our Articles of Incorporation, our authorized share capital consists of 1,950,000,000 common shares, par value $0.001 per share.</font><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">s-2</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin-bottom: 12pt;"><br>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">RISK FACTORS</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-style: italic;">An investment in our common shares is speculative and involves a high degree of risk and uncertainty. You should carefully consider the risks described below
      and discussed under the caption "Risk Factors" in our Annual Report on Form 20-F for the year ended September 30, 2018, filed with the SEC on January 31, 2019, and incorporated by reference herein, as well as the other information included in this
      prospectus supplement and the accompanying prospectus before deciding to invest in our common shares. If any of the risks occur, our business, financial conditions or results of operations may be materially and adversely affected. In that event, the
      trading price of our securities could decline, and you could lose all or part of your investment. This prospectus supplement and the accompanying prospectus also contain forward-looking statements that involve risks and uncertainties. Our actual
      results could differ materially from those anticipated in the forward-looking statements as a result of the risks below.</div>
    <div style="text-align: justify; margin-bottom: 12pt; font-style: italic; font-weight: bold;">Our existing shareholders may experience significant dilution as a result of this offering.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">If we sell all of the 680,191 common shares offered pursuant to this prospectus supplement (assuming a sale price of $4.19, which was the closing price of our common shares on
      June 27, 2019), we will have approximately 3,080,191 common shares outstanding, which represents in the aggregate an increase of approximately 28% in our currently issued and outstanding common shares.&#160; Because the sales of the shares offered hereby
      will be made directly into the market or in negotiated transactions, the prices at which we sell these shares will vary and these variations may be significant.&#160; If we sell all or a substantial portion of the total shares offered pursuant to this
      prospectus supplement, our existing shareholders will experience significant dilution as a result of this offering. An investor that purchases shares offered hereby will experience dilution if, following such purchase, we sell shares at prices
      significantly below the price at which the investor purchased its shares.</div>
    <div style="text-align: justify; margin-bottom: 12pt; font-style: italic; font-weight: bold;">Our Chairman, Chief Executive Officer and Chief Financial Officer, who may be deemed to beneficially own, directly or indirectly, 100% of our Series B
      Preferred Stock, has control over us.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Our Chairman, Chief Executive Officer and Chief Financial Officer, Mr. Petros Panagiotidis, may be deemed to beneficially own, directly or indirectly, all of the 12,000
      outstanding shares of our Series B Preferred Stock.&#160; The shares of Series B Preferred Stock each carry 100,000 votes.&#160; By its ownership of 100% of our Series B Preferred Stock, Mr. Panagiotidis has control over our actions. The interests of Mr.
      Panagiotidis may be different from your interests.</div>
    <div style="text-align: justify; margin-bottom: 12pt; font-style: italic; font-weight: bold;">Our management team will have broad discretion over the use of the net proceeds from this offering.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Our management will use its discretion to direct the use of the net proceeds of this offering. We will use the net proceeds from the sale of the common stock offered by this
      prospectus supplement to opportunistically fund growth opportunities, which may include the purchase of vessels, general corporate purposes or a combination thereof.&#160; As of the date hereof, we have not identified a potential target vessel to acquire.
      We may also use the proceeds to fund our general working capital requirements.Our management's judgments may not result in positive returns on your investment and you will not have an opportunity to evaluate the economic, financial or other
      information upon which our management bases its decisions.</div>
    <div style="text-align: justify; margin-bottom: 12pt; font-style: italic; font-weight: bold;">Future sales of our common stock could cause the market price of our common stock to decline.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The market price of our common shares could decline due to sales, or the announcements of proposed sales, of a large number of common shares in the market, including sales of
      common shares by our large shareholders, or the perception that these sales could occur. These sales or the perception that these sales could occur could also depress the market price of our common shares and impair our ability to raise capital
      through the sale of additional equity securities or make it more difficult or impossible for us to sell equity securities in the future at a time and price that we deem appropriate. We cannot predict the effect that future sales of common shares or
      other equity-related securities would have on the market price of our common shares.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">s-3</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin-bottom: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Our Articles of Incorporation, authorize our Board of Directors to, among other things, issue additional shares of common or preferred stock or securities convertible or
      exchangeable into equity securities, without shareholder approval. We may issue such additional equity or convertible securities to raise additional capital. The issuance of any additional shares of common or preferred stock or convertible securities
      could be substantially dilutive to our shareholders. Moreover, to the extent that we issue restricted stock units, stock appreciation rights, options or warrants to purchase our common stock in the future and those stock appreciation rights, options
      or warrants are exercised or as the restricted stock units vest, our shareholders may experience further dilution. Holders of our common shares have no preemptive rights that entitle such holders to purchase their pro rata share of any offering of
      shares of any class or series and, therefore, such sales or offerings could result in increased dilution to our shareholders.</div>
    <div style="text-align: justify; margin-bottom: 12pt; font-style: italic; font-weight: bold;">Sales of our securities could cause the market price of our common shares to decline.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Sales of a substantial number of our common shares in the public market, as contemplated herein, or the perception that these sales could occur, may depress the market price for
      our common shares, and our shareholders may incur dilution from these sales. These sales could also impair our ability to raise additional capital through the sale of our equity securities in the future.</div>
    <div style="text-align: justify; margin-bottom: 12pt; font-style: italic; font-weight: bold;">Anti-takeover provisions in our organizational documents as well as our stockholders rights agreement could make it difficult for our stockholders to replace
      or remove our current Board of Directors or have the effect of discouraging, delaying or preventing a merger or acquisition, which could adversely affect the market price of our common stock.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Several provisions of our Articles of Incorporation and Amended and By-Laws could make it difficult for our shareholders to change the composition of our Board of Directors in
      any one year, preventing them from changing the composition of management. In addition, the same provisions may discourage, delay or prevent a merger or acquisition that stockholders may consider favorable.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">These provisions include:</div>
    <div style="text-align: justify; margin-bottom: 12pt;">
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z913cd8f2ce2c4fa68d5678b2420288dd">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>authorizing our Board of Directors to issue "blank check" preferred stock without stockholder approval;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt;">
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfed4d2abce29448b9d38653ba580256c">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>providing for a classified Board of Directors with staggered, three-year terms;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt;">
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z70cc5abd6b51405096a66690d690971f">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>prohibiting cumulative voting in the election of directors;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt;">
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za8899c5e26b8438088c12b39e8a29e9a">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>authorizing the removal of directors only for cause and only upon the affirmative vote of the holders of at least 80% of the outstanding shares of our capital stock entitled to vote for the directors;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt;">
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze96014a582194fbc9b9a2dd7d3bdc2e7">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>prohibiting shareholder action by written consent unless the written consent is signed by all shareholders entitled to vote on the action;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt;">
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfe1a21ff12fd4b07939d35c025ae892e">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>limiting the persons who may call special meetings of shareholders;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt;">
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4d50e074e3e74149a2e1f5a00aa0b7aa">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>establishing advance notice requirements for nominations for election to our Board of Directors or for proposing matters that can be acted on by shareholders at shareholder meetings; and</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt;">
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z288a688087c746fabac1ad4b30bbe0d2">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>restricting business combinations with interested shareholders.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">In addition, we have entered into a shareholders rights agreement that will make it more difficult for a third party to acquire significant stake in us without the support of our
      Board of Directors.&#160; Furthermore, the common shares sold in this offering includes a preferred stock purchase right that trades with the common share.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The above anti-takeover provisions and the provisions of our shareholders rights agreement could substantially impede the ability of public stockholders to benefit from a change
      in control and, as a result, may adversely affect the market price of our common stock and your ability to realize any potential change of control premium.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">s-4</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin-bottom: 10pt;"><br>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt; font-style: italic; font-weight: bold;">We are incorporated in the Republic of the Marshall Islands, which does not have a well-developed body of corporate law, and as a result, shareholders may
      have fewer rights and protections under Marshall Islands law than under a typical jurisdiction in the United States.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Our corporate affairs are governed by our Third Amended and Restated Articles of Incorporation, as amended, Amended and Restated By-Laws, as amended, and by the Marshall Islands
      Business Corporations Act, or the BCA. The provisions of the BCA resemble provisions of the corporation laws of a number of states in the United States. However, there have been few judicial cases in the Republic of the Marshall Islands interpreting
      the BCA. The rights and fiduciary responsibilities of directors under the law of the Republic of the Marshall Islands are not as clearly established as the rights and fiduciary responsibilities of directors under statutes or judicial precedent in
      existence in certain United States jurisdictions. Shareholder rights may differ as well. While the BCA does specifically incorporate the non-statutory law, or judicial case law, of the State of Delaware and other states with substantially similar
      legislative provisions, our public shareholders may have more difficulty in protecting their interests in the face of actions by management, directors or controlling shareholders than would shareholders of a corporation incorporated in a United
      States jurisdiction.</div>
    <div style="text-align: justify; margin-bottom: 12pt; font-style: italic; font-weight: bold;">We are a "foreign private issuer," which could make our common stock less attractive to some investors or otherwise harm our stock price.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We are a "foreign private issuer," as such term is defined in Rule 405 under the Securities Act. As a "foreign private issuer" the rules governing the information that we
      disclose differ from those governing U.S. corporations pursuant to the Exchange Act. We are not required to file quarterly reports on Form 10-Q or provide current reports on Form 8-K disclosing significant events within four days of their occurrence.
      In addition, our officers and directors are exempt from the reporting and "short-swing" profit recovery provisions of Section 16 of the Exchange Act and related rules with respect to their purchase and sales of our securities. Our exemption from the
      rules of Section 16 of the Exchange Act regarding sales of common stock by insiders means that you will have less data in this regard than shareholders of U.S. companies that are subject to the Exchange Act. Moreover, we are exempt from the proxy
      rules, and proxy statements that we distribute will not be subject to review by the Commission.&#160; Accordingly there may be less publicly available information concerning us than there is for other U.S. public companies. These factors could make our
      common stock less attractive to some investors or otherwise harm our stock price.</div>
    <div style="text-align: justify; margin-bottom: 12pt; font-style: italic; font-weight: bold;">The actual number of common shares we will issue under the equity distribution agreement, at any one time or in total, is uncertain.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Subject to certain limitations in the equity distribution agreement and compliance with applicable law, we have the discretion to deliver placement notices to Maxim Group LLC at
      any time throughout the term of the equity distribution agreement. The number of shares that are sold by Maxim Group LLC after delivering a placement notice will fluctuate based on the market price of the common shares during the sales period and
      limits we set with Maxim Group LLC.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">s-5</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin-bottom: 10pt;"><br>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">USE OF PROCEEDS</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The net proceeds of this offering will be used to opportunistically fund growth opportunities, which may include the purchase of vessels, general corporate purposes or a
      combination thereof. As of the date hereof, we have not identified a potential target vessel to acquire. We may also use the proceeds to fund our general working capital requirements.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We cannot assure you that we will use the proceeds of this offering for the stated purposes and we may use the net proceeds for other purposes with which you do not agree. See
      "Risk Factors&#8212;We may use the net proceeds of this offering for purposes with which you do not agree."</div>
    <div style="margin-bottom: 12pt;"><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">s-6</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin-bottom: 10pt;"><br>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">CAPITALIZATION</div>
    <div style="margin-bottom: 12pt;">The following table sets forth our consolidated capitalization as of March 31, 2019:</div>
    <div style="margin-bottom: 12pt;">
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zec0751d64eb147de938d4d528549d6a4">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>On an actual basis;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7e8da4cb5f2f4f97920f36dabfc754a4">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>On an as adjusted basis to give effect to the issuance and sale of 680,191 Common Shares at an assumed offering price of&#8201;$4.19 per share, representing the closing price of our common shares on June 27, 2019, resulting in gross proceeds
                  of $2,850,000 and net proceeds of approximately $2,624,500 (after deducting agent's commissions and estimated offering expenses).</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; margin-bottom: 12pt;">There have been no significant adjustments to our capitalization since March 31, 2019, as so adjusted. <font style="background-color: #FFFFFF;">You should read the information below together with
        the section of this prospectus supplement entitled "Use of Proceeds," as well as the consolidated financial statements and related notes for the year ended September 30, 2018, included in our Annual Report on Form 20-F, filed with the Commission on
        January 31, 2019, and our report on Form 6-K which includes our Management's Discussion and Analysis of Financial Condition and Results of Operations for the six months ended March 31, 2019, furnished to the Commission on June 4, 2019, each of
        which is incorporated by reference herein.</font></div>
    <table cellspacing="0" cellpadding="0" id="z0ec8d1e1a05943779cb3399363654463" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

        <tr>
          <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-weight: bold;">As of March 31, 2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-weight: bold;">Actual</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-weight: bold;">As Adjusted</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top;">
            <div style="font-style: italic;">(in U.S. dollars)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top;">
            <div>Debt:</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="margin-left: 12.6pt;">Long-term debt</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div>$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div>&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div>$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div>&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(255, 255, 255);">
            <div>Total debt:</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(255, 255, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div>$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div>&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(255, 255, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(255, 255, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div>$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div>&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(255, 255, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #FFFFFF;">
            <div>Shareholders' Equity:</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="margin-left: 12.6pt;">Common Shares, $0.001 par value, 1,950,000 shares authorized, 2,400,000 shares issued and outstanding on an actual basis and 3,080,191 shares issued and outstanding on an as adjusted basis</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div>$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div>2,400</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div>$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div>3,080</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div><br>
            </div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #FFFFFF;">
            <div style="margin-left: 12.6pt;">Series A Preferred Shares 9.75% cumulative redeemable perpetual preferred shares, $0.001 par value, 480,000 shares issued and outstanding on an actual and as adjusted basis</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;">
            <div>480</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;">
            <div>480</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="margin-left: 12.6pt;">Series B Preferred Shares $0.001 par value, 12,000 shares issued and outstanding on an actual and as adjusted basis</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div>12</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div>12</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #FFFFFF;">
            <div>&#160;&#160;&#160;&#160;Additional paid-in capital</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;">
            <div>7,612,108</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;">
            <div>10,235,928</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">
            <div><br>
            </div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div>&#160;&#160;&#160;&#160;Retained Earnings</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div>1,859,582</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div>1,859,582</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(255, 255, 255);">
            <div>Total Shareholders' Equity:</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div>$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div>9,474,582</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div>$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div>12,099,082</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255);">
            <div><br>
            </div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(255, 255, 255);">
            <div style="font-weight: bold;">Total capitalization</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(255, 255, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div>$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div>9,474,582</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(255, 255, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(255, 255, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div>$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div>12,099,082</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(255, 255, 255);">
            <div><br>
            </div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">s-7</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin-bottom: 12pt;"><br>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">SHARE HISTORY AND MARKETS</div>
    <div style="margin-bottom: 12pt; font-weight: bold;">Share History</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">On September 22, 2017, we entered into an exchange agreement, or the Exchange Agreement, with Spetses and its shareholders.&#160; Under the terms of the Exchange Agreement, we issued
      2,400,000 common shares, 480,000 Series A Preferred Shares and 12,000 Series B Preferred Shares of the Company in exchange for all of the issued and outstanding common shares of Spetses.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">On November 21, 2017, we declared a dividend of one preferred share purchase right for each outstanding common share and adopted a shareholder rights plan, as set forth in a
      Shareholders Rights Agreement dated as of November 20, 2017, by and between us and American Stock Transfer &amp; Trust Company, LLC, as rights agent. For more information, please see "&#8212;Stockholders Rights Agreement" in our annual report of Form 20-F
      for the year ended September 30, 2018, incorporated herein by reference. In connection with the Stockholders Rights Agreement, we designated 1,000,000 shares as Series C Participating Preferred Stock, none of which are outstanding as of the date of
      this prospectus.</div>
    <div style="margin-bottom: 12pt; font-weight: bold;">Markets</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">On December 21, 2018, our common shares, par value $0.001, were registered for trading on the Norwegian OTC (the "NOTC") with ticker symbol "CASTOR".&#160; On February 11, 2019, our
      common shares began trading on the NASDAQ Capital Market under the ticker symbol "CTRM".</div>
    <div style="margin-bottom: 12pt;"><br>
    </div>
    <div style="margin-bottom: 12pt;"><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">s-8</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%9%s-%%-->
    <div style="margin-bottom: 12pt;">
      <div style="text-align: center; font-weight: bold;">TAX CONSIDERATIONS</div>
      <div><br>
      </div>
      <div>You should carefully read the discussion of the material Marshall Islands and U.S. federal income tax considerations associated with our operations and the acquisition, ownership and disposition of our common&#160;shares&#160;set forth in the section
        entitled "Taxation" of our annual report on Form 20-F for the year ended September 30, 2018, filed with the Commission on January 31, 2019 and incorporated by reference herein.</div>
    </div>
    <div style="margin-bottom: 12pt;"><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">s-9</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin-bottom: 10pt;"><br>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">PLAN OF DISTRIBUTION</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt;">We have entered into an equity distribution agreement with Maxim Group LLC pursuant to which we may issue and sell up to an aggregate of $10,000,000 of our common shares from time to time solely
      through Maxim Group LLC acting as sales agent. A copy of the equity distribution agreement will be filed as an exhibit to a Report on Form 6-K and incorporated by reference herein. Our common shares registered under this prospectus supplement are
      subject to sale under such agreement.</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt;">Upon delivery of a placement notice and subject to the terms and conditions of the equity distribution agreement, Maxim Group LLC may sell our common shares by any method permitted by law deemed to
      be an "at-the-market" offering as defined in Rule 415 promulgated under the Securities Act, including sales made directly on the Nasdaq Capital Market, on any other existing trading market for our common shares or to or through a market maker. Maxim
      Group LLC may also sell our common shares by any other method permitted by law, including in privately negotiated transactions. We or Maxim Group LLC may terminate the equity distribution agreement and the offering of our common shares upon notice.</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt;">We will pay Maxim Group LLC in cash, upon each sale of our common shares pursuant to the equity distribution agreement, a commission equal to 3% of the aggregate gross proceeds from the sale of our
      common shares. Because there is no minimum offering amount required as a condition to this offering, the actual total public offering amount, commissions and proceeds to us, if any, are not determinable at this time. We have agreed to reimburse Maxim
      Group LLC upon request for its reasonable costs and out-of-pocket expenses incurred in connection with this offering up to a maximum of$40,000 including fees and disbursements of its legal counsel. Additionally, we have agreed to reimburse Maxim
      Group LLC $7,500 for its legal fees on each bringdown date (as defined in the equity distribution agreement) while this offering is open.</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt;">Settlement for sales of common shares will occur on the second business day following the date on which any sales are made, or on some other date that is agreed upon by us and Maxim Group LLC in
      connection with a particular transaction, in return for payment of the net proceeds to us. There is no arrangement for funds to be received in an escrow, trust or similar arrangement. Sales of our common shares as contemplated in this prospectus
      supplement will be settled through the facilities of The Depository Trust Company or by such other means as we and Maxim Group LLC may agree upon.</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt;">Maxim Group LLC will act as sales agent on a commercially reasonable efforts basis consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations
      and the rules of the Nasdaq Capital Market. In connection with the sale of the common shares on our behalf, Maxim Group LLC will be deemed to be an "underwriter" within the meaning of the Securities Act and the compensation of Maxim Group LLC will be
      deemed to be underwriting commissions or discounts. We have agreed to provide indemnification and contribution to Maxim Group LLC against certain civil liabilities, including liabilities under the Securities Act.</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt;">The offering of our common shares pursuant to the equity distribution agreement will terminate upon the earlier of the (i) sale of all of our common shares provided for in this prospectus supplement,
      or (ii) termination of the equity distribution agreement as permitted therein. We may terminate the equity distribution agreement with five days of prior written notice. Maxim Group LLC may terminate the equity distribution agreement at any time upon
      written notice.</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt;">Maxim Group LLC and its affiliates may in the future provide various investment banking, commercial banking and other financial services for us and our affiliates, for which services they may in the
      future receive customary fees. To the extent required by Regulation M, Maxim Group LLC will not engage in any market making activities involving our common shares while the offering is ongoing under this prospectus supplement.</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt;">This prospectus supplement in electronic format may be made available on a web site maintained by Maxim Group LLC and Maxim Group LLC may distribute this prospectus supplement electronically.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">s-10</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin-bottom: 10pt;"><br>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The following table sets forth information regarding the beneficial owners of 5% or more of our common shares and beneficial ownership of all of our directors and officers. All
      of our shareholders, including the shareholders listed in the table below, are entitled to one vote for each common share held.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The percentage of beneficial ownership is based on 2,400,000 shares outstanding as of as of the date of this prospectus supplement.</div>
    <table cellspacing="0" cellpadding="0" id="z0129e073f85e4460ad7a4b5cd73f466f" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

        <tr>
          <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">
            <div style="font-weight: bold;">Name of Beneficial Owner</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;">
            <div style="font-weight: bold;">No. of Shares</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;">
            <div style="font-weight: bold;">Percentage</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div>Thalassa Investment Co. S.A.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div>1,124,094</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div>46.8</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div>%</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #FFFFFF;">
            <div>Directors and Officers (excluding Petros Panagiotidis)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;">
            <div>0</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;">
            <div>0</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;">
            <div>%</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div>(1) Thalassa Investment Co. S.A., or Thalassa, is a company wholly owned and controlled by Petros Panagiotidis, our Chairman, Chief Executive Officer and Chief Financial Officer. Thalassa also holds 12,000 Series B Preferred Shares. Each share of
      Series B Preferred Shares has the voting power of 100,000 common shares.</div>
    <div style="margin-bottom: 12pt;">&#160;(2) The remaining directors and executive officers of the Company are Dionysios Makris and Georgios Daskalakis.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">s-11</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin-bottom: 10pt;"><br>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We estimate the expenses in connection with the distribution of our common shares in this offering, other than underwriting discounts, will be as set forth in the table below.</div>
    <table cellspacing="0" cellpadding="0" border="0" id="zb43800a5d386448994c3b561a6a0032c" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

        <tr>
          <td valign="bottom" style="vertical-align: top; width: 87%; background-color: rgb(204, 238, 255);">
            <div>SEC registration fee</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div>$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div>340</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 2%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 87%; background-color: rgb(255, 255, 255);">
            <div>Legal fees and expenses</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">
            <div>$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;">
            <div>120,000</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 2%; background-color: rgb(255, 255, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 87%; background-color: rgb(204, 238, 255);">
            <div>FINRA fee</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div>$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div>434</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 2%; background-color: rgb(204, 238, 255);">
            <div><br>
            </div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 87%; background-color: rgb(255, 255, 255);">
            <div>Accounting fees and expenses</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;"><br>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">
            <div>$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;">
            <div>15,000<br>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 2%; background-color: rgb(255, 255, 255);">
            <div><br>
            </div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 87%; background-color: rgb(204, 238, 255);">
            <div>Miscellaneous</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"> 4,226<br>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 2%; background-color: rgb(204, 238, 255);">&#160;<br>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 87%; background-color: rgb(255, 255, 255);">
            <div>Total</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">$</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;">
            <div>140,000<br>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 2%; background-color: rgb(255, 255, 255);">* <br>
          </td>
        </tr>

    </table>
    <div><br>
      ____________</div>
    <div style="text-align: justify;">
      <div>
        <table cellspacing="0" cellpadding="0" id="z95cdccbf267d43d4bcd2c1e4c24b7a47" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman', serif;">*</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman', serif;">All amounts are estimated, except the U.S. Securities and Exchange Commission registration fee of $12,120 and the Financial Industry Regulatory Authority filing of $15,500 covering all the
                  securities being offered under the registration statement on Form F-3 (File No 333-232052) filed with the Commission with an effective date of June 21, 2019, of which this prospectus supplement forms a part, which were previously paid. We
                  allocate the cost of this fee on an approximately pro-rata basis with each offering.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <br>
    <div><br>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">LEGAL MATTERS</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The validity of the common shares offered hereby and other matters relating to Marshall Islands and United States law will be passed upon for us by Seward &amp; Kissel LLP, One
      Battery Park Plaza, New York, New York 10004. Ellenoff Grossman &amp; Schole LLP, New York, New York, is representing the sales agent in this offering.</div>
    <br>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">WHERE YOU CAN FIND ADDITIONAL INFORMATION</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">As required by the Securities Act, we filed a registration statement relating to the securities offered by this prospectus with the Commission. This prospectus is a part of that
      registration statement, which includes additional information.</div>
    <div style="text-align: justify; margin-bottom: 12pt; font-style: italic; font-weight: bold;">Government Filings</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We file annual and special reports with the Commission. The Commission maintains a website (http://www.sec.gov) that contains reports, proxy and information statements and other
      information regarding registrants that file electronically with the Commission.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">This prospectus and any prospectus supplement are part of a registration statement that we filed with the Commission and do not contain all of the information in the registration
      statement. The full registration statement may be obtained from the Commission or us, as indicated below. Forms of the indenture and other documents establishing the terms of the offered securities are filed as exhibits to the registration statement.
      Statements in this prospectus or any prospectus supplement about these documents are summaries and each statement is qualified in all respects by reference to the document to which it refers. You should refer to the actual documents for a more
      complete description of the relevant matters. You may inspect a copy of the registration statement through the Commission's website.</div>
    <div style="text-align: justify; margin-bottom: 12pt; font-style: italic; font-weight: bold;">Information Incorporated by Reference</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The Commission allows us to "incorporate by reference" information that we file with it. This means that we can disclose important information to you by referring you to those
      filed documents. The information incorporated by reference is considered to be a part of this prospectus, and information that we file later with the Commission prior to the termination of this offering will also be considered to be part of this
      prospectus and will automatically update and supersede previously filed information, including information contained in this document.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">s-12</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin-bottom: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We incorporate by reference the documents listed below:</div>
    <div style="text-align: justify; margin-bottom: 12pt;">
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd1b64baa4dfa4110ba3f94d8ba173a9b">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>Current Report on Form 6-K dated June 4, 2019, which includes the unaudited condensed consolidated interim financial statements and related Management's Discussion and Analysis of Financial Condition and Results of Operations of the
                  Company for the six months ended March 31, 2019.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt;">
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfbec5d7df17b4e5fb87383918e30ed8e">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>The description of the preferred share purchase rights set forth in our Registration Statement on Form 8-A, filed with the Commission March 21, 2019.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt;">
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z91b8f9a054f94027932d686aad566acf">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>The description of our common share set forth in our Registration Statement on Form 8-A/A, filed with the Commission on February 8, 2019, as amended.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt;">
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z740cedd488ea488792b4b0c2d58740f4">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>Annual Report on Form 20-F for the year ended Annual Report on Form 20-F for the year ended September 30, 2018, filed with the Commission on January 31, 2019 and as amended by a Form 20-F/A filed with the Commission on March 1, 2019.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt;">
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z25d6a62465a4462b89d044b0bf99337a">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>Exhibits 3.3, 3.4 and 3.5 of the Form F-4 Registration Statement declared effective on May 2, 2018, which contain the Statements of Designations of the Series A, Series B and Series C Preferred Shares of the Company, respectively.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We are also incorporating by reference all subsequent annual reports on Form 20-F that we file with the Commission and certain reports on Form 6-K that we furnish to the
      Commission after the date of this prospectus (if they state that they are incorporated by reference into this prospectus) until we file a post-effective amendment indicating that the offering of the securities made by this prospectus has been
      terminated. In all cases, you should rely on the later information over different information included in this prospectus or any prospectus supplement.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">You should rely only on the information contained or incorporated by reference in this prospectus and subsequent filings. We have not, and any underwriters have not, authorized
      any other person to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We are not, and the underwriters are not, making an offer to sell these securities in any
      jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus and any accompanying prospectus supplement as well as the information we previously filed with the Commission and incorporated
      by reference, is accurate as of the dates on the front cover of those documents only. Our business, financial condition and results of operations and prospects may have changed since those dates.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">You may request a free copy of the above mentioned filings or any subsequent filing we incorporated by reference to this prospectus by oral or written request to the following
      address:</div>
    <div style="text-align: center;">Castor Maritime Inc.</div>
    <div style="text-align: center;">Attn: Petros Panagiotidis</div>
    <div style="text-align: center;">Christodoulou Chatzipavlou 223</div>
    <div style="text-align: center;">Hawaii Royal Gardens, Apart. 16</div>
    <div style="text-align: center;">3036 Limassol</div>
    <div style="text-align: center;">Cyprus</div>
    <div style="text-align: center;">+ 357 25 357 767</div>
    <div style="text-align: center;">www.castormaritime.com</div>
    <div><br>
    </div>
    <div style="margin-bottom: 12pt; font-weight: bold;">Information provided by the Company</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We will furnish holders of our common shares with annual reports containing audited financial statements and a report by our independent registered public accounting firm. The
      audited financial statements will be prepared in accordance with United States generally accepted accounting principles and those reports will include a "Management's Discussion and Analysis of Financial Condition and Results of Operations" section
      for the relevant periods. As a "foreign private issuer," we are exempt from the rules under the Securities Exchange Act prescribing the furnishing and content of proxy statements to shareholders. While we intend to furnish proxy statements to any
      shareholder in accordance with the rules of the NASDAQ, those proxy statements are not expected to conform to Schedule 14A of the proxy rules promulgated under the Exchange Act. In addition, as a "foreign private issuer," we are exempt from the rules
      under the Exchange Act relating to short swing profit reporting and liability.</div>
    <div style="margin-bottom: 12pt; font-weight: bold;">Disclosure of Commission Position on Indemnification for Securities Act Liabilities</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the registrant pursuant to the
      foregoing provisions, the registrant has been informed that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is therefore unenforceable.</div>
  </div>
  <br>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">s-13</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <br>
  <div><br>
  </div>
  <div><br>
  </div>
  <div><br>
  </div>
  <br>
  <div><br>
  </div>
  <div style="text-align: justify; margin-bottom: 36pt; color: rgb(255, 0, 0);"><font style="font-weight: bold; font-variant: small-caps;">The information in this prospectus is not complete and may be changed. This prospectus is not an offer to sell these
      securities and it is not soliciting an offer to buy or sell these securities in any jurisdiction where the offer or sale is not permitted. These securities may not be sold until the registration statement filed with the U.S. Securities and Exchange
      Commission is effective.</font></div>
  <div style="text-align: left;"><font style="font-weight: bold;">Prospectus</font></div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-size: 18pt; font-weight: bold;">$100,000,000</font></div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', serif; font-size: 24pt; font-weight: bold;">CASTOR MARITIME INC.</font></div>
  <div style="text-align: center;"><font style="font-weight: bold;">Common Shares, Preferred Share Purchase Rights, Preferred Shares,</font></div>
  <div style="text-align: center;"><font style="font-weight: bold;">Debt Securities, Warrants, Purchase Contracts, Rights and Units</font></div>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse;" id="z1c0aba31a2944af7810ce892d5e27e9f">

      <tr>
        <td style="width: 100%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
      </tr>

  </table>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Through this prospectus, we may periodically offer:</div>
  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse;" id="z31a70334f139467e9a4cd21ff5dcb708">

      <tr>
        <td style="width: 5%; vertical-align: middle;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">
          <div style="text-align: left;">(1)</div>
        </td>
        <td style="width: 90%; vertical-align: top;">
          <div style="text-align: left;">our common shares (including preferred share purchase rights),</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: middle;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">&#160;</td>
        <td style="width: 90%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: middle;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">
          <div style="text-align: left;">(2)</div>
        </td>
        <td style="width: 90%; vertical-align: top;">
          <div style="text-align: left;">our preferred shares,</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: middle;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">&#160;</td>
        <td style="width: 90%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: middle;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">
          <div style="text-align: left;">(3)</div>
        </td>
        <td style="width: 90%; vertical-align: top;">
          <div style="text-align: left;">our debt securities<font style="background-color: #FFFFFF;">,</font></div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: middle;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">&#160;</td>
        <td style="width: 90%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: middle;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">
          <div style="text-align: left;">(4)</div>
        </td>
        <td style="width: 90%; vertical-align: top;">
          <div style="text-align: left;">our warrants,</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: middle;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">&#160;</td>
        <td style="width: 90%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: middle;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">
          <div style="text-align: left;">(5)</div>
        </td>
        <td style="width: 90%; vertical-align: top;">
          <div style="text-align: left;">our purchase contracts</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: middle;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">&#160;</td>
        <td style="width: 90%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: middle;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">
          <div style="text-align: left;">(6)</div>
        </td>
        <td style="width: 90%; vertical-align: top;">
          <div style="text-align: left;">our rights, and</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: middle;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">&#160;</td>
        <td style="width: 90%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: middle;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">
          <div style="text-align: left;">(7)</div>
        </td>
        <td style="width: 90%; vertical-align: top;">
          <div style="text-align: left;">our units.</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The prices and other terms of the securities that we will offer will be determined at the time of their offering and will be described in a supplement to this prospectus.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The securities issued under this prospectus may be offered directly or through underwriters, agents or dealers. The names of any underwriters, agents or dealers will be included in
    a supplement to this prospectus.</div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-weight: bold;">An investment in these securities involves a high degree of risk. See the section entitled &#8220;Risk Factors&#8221; on page 5 of this prospectus, and other risk
      factors contained in the applicable prospectus supplement and in the documents incorporated by reference herein and therein.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-weight: bold;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if
      this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</font></div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">The date of this prospectus is June 21, 2019.</font></div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <!--PROfilePageNumberReset%LCR%1%%%-->
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold; font-variant: small-caps;">Table of Contents</font></div>
  <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse;" id="z47e602980b46490bb91dd4dc11811c34">

      <tr>
        <td style="width: 86.02%; vertical-align: top;">
          <div style="text-align: left;">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</div>
        </td>
        <td style="width: 13.98%; vertical-align: top;">
          <div style="text-align: right;">2</div>
        </td>
      </tr>
      <tr>
        <td style="width: 86.02%; vertical-align: top;">
          <div style="text-align: left;">PROSPECTUS SUMMARY</div>
        </td>
        <td style="width: 13.98%; vertical-align: top;">
          <div style="text-align: right;">4</div>
        </td>
      </tr>
      <tr>
        <td style="width: 86.02%; vertical-align: top;">
          <div style="text-align: left;">RISK FACTORS</div>
        </td>
        <td style="width: 13.98%; vertical-align: top;">
          <div style="text-align: right;">5</div>
        </td>
      </tr>
      <tr>
        <td style="width: 86.02%; vertical-align: top;">
          <div style="text-align: left;">SHARE HISTORY AND MARKETS</div>
        </td>
        <td style="width: 13.98%; vertical-align: top;">
          <div style="text-align: right;">6</div>
        </td>
      </tr>
      <tr>
        <td style="width: 86.02%; vertical-align: top;">
          <div style="text-align: left;">USE OF PROCEEDS</div>
        </td>
        <td style="width: 13.98%; vertical-align: top;">
          <div style="text-align: right;">7</div>
        </td>
      </tr>
      <tr>
        <td style="width: 86.02%; vertical-align: top;">
          <div style="text-align: left;">CAPITALIZATION</div>
        </td>
        <td style="width: 13.98%; vertical-align: top;">
          <div style="text-align: right;">8</div>
        </td>
      </tr>
      <tr>
        <td style="width: 86.02%; vertical-align: top;">
          <div style="text-align: left;">ENFORCEMENT OF CIVIL LIABILITIES</div>
        </td>
        <td style="width: 13.98%; vertical-align: top;">
          <div style="text-align: right;">9</div>
        </td>
      </tr>
      <tr>
        <td style="width: 86.02%; vertical-align: top;">
          <div style="text-align: left;">PLAN OF DISTRIBUTION</div>
        </td>
        <td style="width: 13.98%; vertical-align: top;">
          <div style="text-align: right;">10</div>
        </td>
      </tr>
      <tr>
        <td style="width: 86.02%; vertical-align: top;">
          <div style="text-align: left;">DESCRIPTION OF SHARE CAPITAL</div>
        </td>
        <td style="width: 13.98%; vertical-align: top;">
          <div style="text-align: right;">12</div>
        </td>
      </tr>
      <tr>
        <td style="width: 86.02%; vertical-align: top;">
          <div style="text-align: left;">DESCRIPTION OF DEBT SECURITIES</div>
        </td>
        <td style="width: 13.98%; vertical-align: top;">
          <div style="text-align: right;">19</div>
        </td>
      </tr>
      <tr>
        <td style="width: 86.02%; vertical-align: top;">
          <div style="text-align: left;">DESCRIPTION OF WARRANTS</div>
        </td>
        <td style="width: 13.98%; vertical-align: top;">
          <div style="text-align: right;">25</div>
        </td>
      </tr>
      <tr>
        <td style="width: 86.02%; vertical-align: top;">
          <div style="text-align: left;">DESCRIPTION OF PURCHASE CONTRACTS</div>
        </td>
        <td style="width: 13.98%; vertical-align: top;">
          <div style="text-align: right;">26</div>
        </td>
      </tr>
      <tr>
        <td style="width: 86.02%; vertical-align: top;">
          <div style="text-align: left;">DESCRIPTION OF RIGHTS</div>
        </td>
        <td style="width: 13.98%; vertical-align: top;">
          <div style="text-align: right;">27</div>
        </td>
      </tr>
      <tr>
        <td style="width: 86.02%; vertical-align: top;">
          <div style="text-align: left;">DESCRIPTION OF UNITS</div>
        </td>
        <td style="width: 13.98%; vertical-align: top;">
          <div style="text-align: right;">28</div>
        </td>
      </tr>
      <tr>
        <td style="width: 86.02%; vertical-align: top;">
          <div style="text-align: left;">EXPENSES</div>
        </td>
        <td style="width: 13.98%; vertical-align: top;">
          <div style="text-align: right;">29</div>
        </td>
      </tr>
      <tr>
        <td style="width: 86.02%; vertical-align: top;">
          <div style="text-align: left;">LEGAL MATTERS</div>
        </td>
        <td style="width: 13.98%; vertical-align: top;">
          <div style="text-align: right;">29</div>
        </td>
      </tr>
      <tr>
        <td style="width: 86.02%; vertical-align: top;">
          <div style="text-align: left;">EXPERTS</div>
        </td>
        <td style="width: 13.98%; vertical-align: top;">
          <div style="text-align: right;">29</div>
        </td>
      </tr>
      <tr>
        <td style="width: 86.02%; vertical-align: top;">
          <div style="text-align: left;">WHERE YOU CAN FIND ADDITIONAL INFORMATION</div>
        </td>
        <td style="width: 13.98%; vertical-align: top;">
          <div style="text-align: right;">29</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">i</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <!--PROfilePageNumberReset%Num%1%%%-->
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;"><font style="background-color: #FFFFFF;">ABOUT THIS PROSPECTUS</font></font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">This prospectus is part of a registration statement filed with the U.S. Securities and Exchange Commission, or the Commission, using a shelf registration process. Under the shelf
    registration process, we may sell our common shares (including preferred share purchase rights), preferred shares, debt securities, warrants, purchase contracts and units described in this prospectus in one or more offerings. This prospectus provides
    you with a general description of the securities we may offer. Each time we offer securities, we will provide you with a prospectus supplement that will describe the specific amounts, prices and terms of the offered securities. We may file a prospectus
    supplement in the future that may also add, update or change the information contained in this prospectus. You should read carefully both this prospectus and any prospectus supplement, together with the additional information described below.</div>
  <div style="text-align: justify; text-indent: 27pt; margin-bottom: 12pt;">This prospectus and any prospectus supplement are part of a registration statement we have filed with the Commission and do not contain all the information in the registration
    statement. Forms of the indentures and other documents establishing the terms of the offered securities are filed as exhibits to the registration statement. Statements in this prospectus or any prospectus supplement about these documents are summaries
    and each statement is qualified in all respects by reference to the document to which it refers. You should refer to the actual documents for a more complete description of the relevant matters. For further information about us or the securities
    offered hereby, you should refer to the registration statement, which you can obtain from the Commission as described below under the section entitled &#8220;Where You Can Find Additional Information.&#8221;</div>
  <div style="text-align: justify; text-indent: 27pt; margin-bottom: 12pt;">You should rely only on the information contained or incorporated by reference in this prospectus and in any prospectus supplement. We have not authorized any other person to
    provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. You should assume that the information appearing in this prospectus and the applicable supplement to this prospectus
    is accurate as of the date on its respective cover, and that any information incorporated by reference is accurate only as of the date of the document incorporated by reference, unless we indicate otherwise. Our business, financial condition, results
    of operations and prospects may have changed since those dates.</div>
  <div style="text-align: justify; text-indent: 27pt; margin-bottom: 12pt;">Other than in the United States, no action has been taken by us or any underwriters that would permit a public offering of the common shares offered by this prospectus in any
    jurisdiction where action for that purpose is required. The common shares offered by this prospectus may not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with the
    offer and sale of any such shares be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus
    comes are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any common shares
    offered by this prospectus in any jurisdiction in which such an offer or a solicitation is unlawful.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">1</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Certain matters discussed herein may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for
    forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and
    underlying assumptions and other statements, which are other than statements of historical facts.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The Company desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection
    with this safe harbor legislation. This report and any other written or oral statements made by us or on our behalf may include forward-looking statements, which reflect our current views with respect to future events and financial performance, and are
    not intended to give any assurance as to future results. When used in this document, the words &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;likely,&#8221; &#8220;may,&#8221; &#8220;could&#8221; and similar expressions, terms, or phrases may
    identify forward-looking statements.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The forward-looking statements are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, our management's
    examination of historical operating trends, data contained in our records and other data available from third parties. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant
    uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, we cannot assure you that we will achieve or accomplish these expectations, beliefs or projections. We undertake no obligation to update any
    forward-looking statement, whether as a result of new information, future events or otherwise.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">In addition to these assumptions and matters discussed elsewhere herein and in the documents incorporated by reference herein, important factors that, in our view, could cause
    actual results to differ materially from those discussed in the forward-looking statements include the following:</div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z37c1decfa0bd42b8b2c64299bafdb872">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>general dry bulk shipping market conditions, including fluctuations in charter rates and our Vessel&#8217;s value;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zfef52f69279a43acacbc33282cb698f6">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>our future operating or financial results;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zc706583a85c749e1a46f08964f198dfd">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>our ability to procure or have access to financing, our liquidity and the adequacy of cash flows for our operations;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zf70076e0f0e64970a96525d07456713d">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>our ability to successfully employ our Vessel;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zc58a813257c844a1bdee06d139f4569c">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div><font style="background-color: #FFFFFF;">changes in demand in the dry bulk shipping industry, including the market for our Vessel;</font></div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zb5ef49df1cbd4fd4ba4f130d24e3b51c">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>changes in our operating expenses, including bunker prices, dry docking and insurance costs;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z64ec6dc971514f4dad73d5c3fcbe1362">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div><font style="background-color: #FFFFFF;">our ability to meet requirements for additional capital and financing to grow our business;</font></div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z9d0c2040145d44fc958cdfefed7a042a">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>planned or pending acquisitions, business strategy and expected capital spending or operating expenses, including dry-docking, surveys, upgrades and insurance costs;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="ze7020286bffb435288529893064dc20b">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div><font style="background-color: #FFFFFF;">changes in governmental rules and regulations or actions taken by regulatory authorities;</font></div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z7d310a933957451b92bcb1e696f89d7e">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>our expectations regarding the availability of vessel acquisitions and our ability to complete acquisition transactions as planned;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z1c3b7355079f4ca2b10830033a8ea94d">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>Vessel breakdowns and instances of off-hire;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zd10bb0f724c143b98b595d7c8ddea62c">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>potential conflicts of interest involving members of our board of directors, or the Board, and senior management;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z4d4e864152804aed8fc5ce32ef512667">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>potential liability from pending or future litigation;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zcf4fdb1da57448f5985becd5fd6289ee">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>potential exposure or loss from investment in derivative instruments;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z595851bcf1924789ae0365a8f2e0e83e">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>forecasts of our ability to make cash distributions on our common units or any increases in our cash distributions</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">2</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z5bb22ee0b5b4463cab08183cc8be249c">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>our ability to make additional borrowings and to access debt and equity markets</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z7a9aec2eb0c04fc7b8fddcf4f362b2f0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the strength of world economies;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z7983fb1a93534fbbbfbfe60f5f13bc71">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>stability of Europe and the Euro;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z8534aaefd03e49d3af3e07b9f8165c7e">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>fluctuations in interest rates and foreign exchange rates;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z906ef162f1c14d73bd34afb65aef0aba">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>changes in seaborne and other transportation;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z88f2755a1b634cc1852f0b99a4bbcac7">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>our anticipated incremental general and administrative expenses as a publicly traded company and our fees and expenses payable under the Vessel management agreement with our Manager;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z83d371a23bd64b3a854bbc003849837d">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>general domestic and international political conditions;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z29463aee4e3244cd9299a9a83b0df582">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>our business strategy and other plans and objectives for future operations;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="ze90d137599c244d59c3074db616bd1b0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>termination dates and extensions of charters; and</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z053763f6117e4159b17df93e15c0eec5">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>potential disruption of shipping routes due to accidents or political events.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Any forward-looking statements contained herein are made only as of the date of this prospectus, and&#160;we undertake no obligation to update any forward-looking statement or
    statements to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for us to predict all or any of these
    factors. Further, we cannot assess the impact of each such factor on our business or the extent to which any factor, or combination of factors, may cause actual results to be materially different from those contained in any forward-looking statement.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">3</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">PROSPECTUS SUMMARY</font></div>
  <div style="text-align: justify; margin-bottom: 12pt;"><font style="font-style: italic;">This summary provides an overview of our company and our business. This summary is not complete and does not contain all of the information you should consider
      before purchasing our securities. You should carefully read all of the information contained or incorporated by reference in this prospectus and any accompanying prospectus supplement, including the &#8220;Risk Factors&#8221; and our consolidated financial
      statements and related notes contained herein and therein, before making an investment decision. Unless we specify otherwise, all references in this prospectus to &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; and the &#8220;Company&#8221; refer to Castor Maritime Inc. We use the term
      deadweight, or &#8220;dwt,&#8221; in describing the size of our Vessel. Dwt, expressed in metric tons each of which is equivalent to 1,000 kilograms, refers to the maximum weight of cargo and supplies that a vessel can carry.</font></div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Our Company</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We are a growth-oriented global shipping company engaged in the seaborne transportation of a wide range of dry bulk commodities including, among others, iron ore, coal and grain,
    collectively referred to as "major bulks," and steel products, fertilizers, cement, bauxite, sugar and scrap metal, collectively referred to as "minor bulks". We were incorporated in the Republic of the Marshall Islands on September 11, 2017.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">On September 22, 2017, we entered into an all-share exchange transaction (the "Magic P Purchase Transaction") pursuant to which we acquired 100% of the issued and outstanding
    capital stock of our sole wholly-owned subsidiary Spetses Shipping Co. ("Spetses"), a Marshall Islands corporation, which owns a 76,453 dwt drybulk carrier, the Magic P, or our Vessel. The consideration for the Magic P Purchase transaction involved the
    issuance of 2,400,000 common shares, 480,000 9.75% Series A Cumulative Redeemable Perpetual Preferred Shares (the "Series A Preferred Shares") and 12,000 non-interest bearing Series B Preferred Shares (the "Series B Preferred Shares") to the then
    existing shareholders of Spetses.</div>
  <div style="text-align: justify; margin-bottom: 12pt;"><font style="font-weight: bold;">Our Fleet</font></div>
  <div style="text-align: justify; margin-bottom: 12pt;">Our Fleet is currently comprised of our Vessel. The following table summarizes key information about our Vessel as of the date of this prospectus:</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse;" id="zd89cacf1c5b54f27bb00eecc9ec231f5">

      <tr>
        <td style="width: 12.16%; vertical-align: bottom; border-bottom: #000000 2px solid;">
          <div style="text-align: left;"><font style="font-weight: bold;">Vessel Name</font></div>
        </td>
        <td style="width: 10.82%; vertical-align: bottom; border-bottom: #000000 2px solid;">
          <div style="text-align: center;"><font style="font-weight: bold;">Year Built</font></div>
        </td>
        <td style="width: 16.4%; vertical-align: top; border-bottom: #000000 2px solid;">
          <div style="text-align: center;"><font style="font-weight: bold;">Type of Charter</font></div>
        </td>
        <td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 2px solid;">&#160;</td>
        <td colspan="2" style="width: 11.86%; vertical-align: bottom; border-bottom: #000000 2px solid;">
          <div style="text-align: center;"><font style="font-weight: bold;">Capacity (dwt)</font></div>
        </td>
        <td style="width: 13.5%; vertical-align: bottom; border-bottom: #000000 2px solid;">
          <div style="text-align: center;"><font style="font-weight: bold;">Delivered to Castor</font></div>
        </td>
        <td style="width: 17.1%; vertical-align: bottom; border-bottom: #000000 2px solid;">
          <div style="text-align: center;"><font style="font-weight: bold;">Earliest Charter Expiration</font></div>
        </td>
        <td style="width: 17.1%; vertical-align: bottom; border-bottom: #000000 2px solid;">
          <div style="text-align: center;"><font style="font-weight: bold;">Latest Charter Expiration</font></div>
        </td>
      </tr>
      <tr>
        <td style="width: 12.16%; vertical-align: bottom; background-color: #CCEEFF;">
          <div style="background-color: #CCEEFF;">
            <div style="text-align: left;"><font style="font-style: italic;">Magic P</font></div>
          </div>
        </td>
        <td style="width: 10.82%; vertical-align: bottom; background-color: #CCEEFF;">
          <div style="background-color: #CCEEFF;">
            <div style="text-align: center;">2004</div>
          </div>
        </td>
        <td style="width: 16.4%; vertical-align: bottom; background-color: #CCEEFF;">
          <div style="background-color: #CCEEFF;">
            <div style="text-align: center;">Time Charter</div>
          </div>
        </td>
        <td style="width: 1.06%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
        <td style="width: 2.4%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
        <td style="width: 9.46%; vertical-align: bottom; background-color: #CCEEFF;">
          <div style="background-color: #CCEEFF;">
            <div style="text-align: center;">76,453</div>
          </div>
        </td>
        <td style="width: 13.5%; vertical-align: bottom; background-color: #CCEEFF;">
          <div style="background-color: #CCEEFF;">
            <div style="text-align: center;">September 2017</div>
          </div>
        </td>
        <td style="width: 17.1%; vertical-align: bottom; background-color: #CCEEFF;">
          <div style="background-color: #CCEEFF;">
            <div style="text-align: center;">August 2019</div>
          </div>
        </td>
        <td style="width: 17.1%; vertical-align: bottom; background-color: #CCEEFF;">
          <div style="background-color: #CCEEFF;">
            <div style="text-align: center;">November 2019 <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
          </div>
        </td>
      </tr>

  </table>
  <div style="background-color: #FFFFFF;">
    <div><br>
    </div>
  </div>
  <div style="background-color: #FFFFFF;">
    <div style="text-align: left; margin-bottom: 12pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" id="TRGRRTFtoHTMLTab">&#160;</font>On March 12, 2019, the Magic P commenced employment under a time charter
      with Oldendorff Carriers GMBH &amp; Co KG Luebeck&#160;at a gross charter rate of $11,250 per day (for the first 30-day period, the daily gross rate was $9,000 per day). The respective charter has a minimum term of five (5) months, up to a maximum term of
      eight (8) months (plus or minus fifteen days).</div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Ship Management</font></div>
    <div><br>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The ship management of our Vessel is provided by Pavimar, a company controlled by Ismini Panagiotidis, the sister of our Chairman, Chief Executive Officer and Chief Financial
    Officer, Petros Panagiotidis. Under the management agreement, Pavimar provides us with a wide range of shipping services such as crew management, technical management, operational employment management, insurance arrangements, provisioning, bunkering,
    accounting services, general administration and audit support.&#160; From December 16, 2017, onwards and for a period of two years thereof, the fixed daily management fee of our Vessel is $320, at which time the daily management fee may be revised.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">4</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">RISK FACTORS</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">An investment in our securities involves a high degree of risk.&#160; You should carefully consider the risks set forth below and the discussion of risks under the heading &#8220;Item 3. Key
    Information&#8212;D. Risk Factors&#8221; in our Annual Report on Form 20-F for the year ended September 30, 2018, as amended, filed with the Commission on January 31, 2019, and the other documents which are incorporated by reference in this prospectus, before
    making an investment in our securities.&#160; Please see the section of this prospectus entitled &#8220;Where You Can Find Additional Information&#8212;Information Incorporated by Reference.&#8221;&#160; In addition, you should also consider carefully the risks set forth under
    the heading &#8220;Risk Factors&#8221; in any prospectus supplement before investing in the securities offered by this prospectus. The occurrence of one or more of those risk factors could adversely impact our business, financial condition or results of
    operations.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold; font-style: italic;">We may issue additional common shares or other equity securities without your approval, which would dilute your ownership interests and may depress
      the market price of our common shares.</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We may issue additional common shares or other equity securities of equal or senior rank in the future in connection with, among other things, future vessel acquisitions, repayment
    of future outstanding indebtedness or payment of dividends under our preferred class of shares, without shareholder approval, in a number of circumstances.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Our issuance of additional common shares or other equity securities of equal or senior rank would have the following effects:</div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z1f6f8413752d4970bd0310727c3c4089">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>our existing shareholders' proportionate ownership interest in us may decrease;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z83e851b261c8464b96fd362f94db30c3">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the amount of cash available for dividends payable on our common shares may decrease;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z368faa08401e490abcb5a527f8739b7d">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the relative voting strength of each previously outstanding common share may be diminished; and</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z4b2fe370947f4ac3906ffee7c2c6cf5d">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the market price of our common shares may decline.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">5</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">SHARE HISTORY AND MARKETS</font></div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Share History</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">On September 22, 2017, we entered into an exchange agreement, or the Exchange Agreement, with Spetses and its shareholders.&#160; Under the terms of the Exchange Agreement, we issued
    2,400,000 common shares, 480,000 Series A Preferred Shares and 12,000 Series B Preferred Shares of the Company in exchange for all of the issued and outstanding common shares of Spetses.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">On November 21, 2017, we declared a dividend of one preferred share purchase right for each outstanding common share and adopted a shareholder rights plan, as set forth in a
    Stockholders Rights Agreement dated as of November 20, 2017, by and between us and American Stock Transfer &amp; Trust Company, LLC, as rights agent. For more information, please see &#8220;&#8212;Stockholders Rights Agreement&#8221; herein. In connection with the
    Stockholders Rights Agreement, we designated 1,000,000 shares as Series C Participating Preferred Stock, none of which are outstanding as of the date of this prospectus.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Markets</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">On December 21, 2018, our common shares, par value $0.001, were registered for trading on the Norwegian OTC (the &#8220;NOTC&#8221;) with ticker symbol &#8220;CASTOR&#8221;.&#160; On February 11, 2019, our
    common shares began trading on the NASDAQ Capital Market under the ticker symbol &#8220;CTRM&#8221;.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">6</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">USE OF PROCEEDS</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Unless we specify otherwise in any prospectus supplement, we may use the net proceeds from the sale of securities offered by this prospectus for capital expenditures, working
    capital, to make vessel or other asset acquisitions or for general corporate purposes or a combination thereof.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">7</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: left;"><br>
  </div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">CAPITALIZATION</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Each prospectus supplement will include information on the Company's consolidated capitalization.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">8</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">ENFORCEMENT OF CIVIL LIABILITIES</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We are incorporated under the laws of the Republic of the Marshall Islands, and substantially all of our assets are located outside of the United States. Our principal executive
    office is located in Cyprus. In addition, all of our directors and officers are non-residents of the United States, and substantially all of their assets are located outside the United States. As a result, it may be difficult or impossible for you to
    bring an action against us or against these individuals in the United States if you believe that your rights have been infringed under securities laws or otherwise. Even if you are successful in bringing an action of this kind, the laws of the Republic
    of the Marshall Islands and of other jurisdictions may prevent or restrict you from enforcing a judgment against our assets or our directors and officers. Although you may bring an original action against us or our affiliates in the courts of the
    Marshall Islands, and the courts of the Marshall Islands may impose civil liability, including monetary damages, against us or our affiliates for a cause of action arising under Marshall Islands law, it may be impracticable for you to do so.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">9</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">PLAN OF DISTRIBUTION</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We may sell or distribute the securities included in this prospectus through underwriters, through agents, to dealers, in private transactions, at market prices prevailing at the
    time of sale, at prices related to the prevailing market prices, or at negotiated prices.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">In addition, we may sell some or all of the securities included in this prospectus through:</div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z79927daaf33949d09943c543bae5ff76">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>a block trade in which a broker-dealer may resell a portion of the block, as principal, in order to facilitate the transaction;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="ze36fd84a72a44539b6eb0ec70ff0390a">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>purchases by a broker-dealer, as principal, and resale by the broker-dealer for its account;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z4503450281bd484fabc1f32682f472ac">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>ordinary brokerage transactions and transactions in which a broker solicits purchasers; or</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z89166aa7ed554bc49d1f46bdd54e6d1d">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>trading plans entered into by us pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, that are in place at the time of an offering pursuant to this prospectus and any applicable prospectus
                supplement hereto that provide for periodic sales of our securities on the basis of parameters described in such trading plans.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">In addition, we may enter into options or other types of transactions that require us to deliver our securities to a broker-dealer, who will then resell or transfer the securities
    under this prospectus. We may enter into hedging transactions with respect to our securities. For example, we may:</div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zf7508964f35b4a0f99e267c82801a98f">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>enter into transactions involving short sales of our common shares by broker-dealers;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z15b8a5e46c304729ad39a2aeb0000056">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>sell common shares short and deliver the shares to close out short positions;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z33301331328d4894b09c1577d10bbd3b">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>enter into option or other types of transactions that require us to deliver common shares to a broker-dealer, who will then resell or transfer the common shares under this prospectus; or</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z7451e00a28ff4f2cba43295e558600e5">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>loan or pledge the common shares to a broker-dealer, who may sell the loaned shares or, in the event of default, sell the pledged shares.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the
    applicable prospectus supplement indicates, in connection with those derivatives, the third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party
    may use securities pledged by us or borrowed from us to settle those sales or to close out any related open borrowings of stock, and may use securities received from us in settlement of those derivatives to close out any related open borrowings of
    stock. The third party in such sale transactions will be an underwriter and, if not identified in this prospectus, will be identified in the applicable prospectus supplement (or a post-effective amendment). In addition, we may otherwise loan or pledge
    securities to a financial institution or other third party that in turn may sell the securities short using this prospectus. Such financial institution or other third party may transfer its economic short position to investors in our securities or in
    connection with a concurrent offering of other securities.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Any broker-dealers or other persons acting on our behalf that participate with us in the distribution of the securities, may be deemed to be underwriters, and any commissions
    received or profit realized by them on the resale of the securities, may be deemed to be underwriting discounts and commissions under the Securities Act of 1933, as amended, or the Securities Act.&#160; As of the date of this prospectus, we are not a party
    to any agreement, arrangement or understanding between any broker or dealer and us with respect to the offer or sale of the securities pursuant to this prospectus.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">10</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">At the time that any particular offering of securities is made, to the extent required by the Securities Act, a prospectus supplement will be distributed, setting forth the terms
    of the offering, including the aggregate number of securities being offered, the purchase price of the securities, the initial offering price of the securities, the names of any underwriters, dealers or agents, any discounts, commissions and other
    items constituting compensation from us and any discounts, commissions or concessions allowed or re-allowed or paid to dealers. Furthermore, we, our executive officers, our directors and major shareholders may agree, subject to certain exemptions, that
    for a certain period from the date of the prospectus supplement under which the securities are offered, we and they will not, without the prior written consent of an underwriter, offer, sell, contract to sell, pledge or otherwise dispose of any of our
    common shares or any securities convertible into or exchangeable for our common shares.&#160; However, an underwriter, in its sole discretion, may release any of the securities subject to these lock-up agreements at any time without notice. We expect an
    underwriter to exclude from these lock-up agreements securities exercised and/or sold pursuant to trading plans entered into by us pursuant to Rule 10b5-1 under the Exchange Act, that are in place at the time of an offering pursuant to this prospectus
    and any applicable prospectus supplement hereto that provide for periodic sales of our securities on the basis of parameters described in such trading plans.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Underwriters or agents could make sales in privately negotiated transactions and/or any other method permitted by law, including sales deemed to be an at-the-market offering as
    defined in Rule 415 promulgated under the Securities Act, which includes sales made directly on or through the NASDAQ, the existing trading market for our common shares, or sales made to or through a market maker other than on an exchange.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We will bear costs relating to the securities offered and sold under this Registration Statement.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">If more than five percent (5%) of the net proceeds of any offering of common shares made under this prospectus will be received by a Financial Industry Regulatory Authority, or
    FINRA, member participating in the offering or affiliates or associated persons of such a FINRA member, the offering will be conducted in accordance with FINRA Rule 5121.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">11</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">DESCRIPTION OF SHARE CAPITAL</font></div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Authorized Capitalization</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Under our articles of incorporation, our authorized capital stock consists of 1,950,000,000 common shares, par value $0.001 per share, of which 2,400,000 common shares are issued
    and outstanding and 50,000,000 preferred shares, par value $0.001 per share, of which 480,000 Series A Preferred Shares and 12,000 Series B Preferred Shares are issued and outstanding.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Share History</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">On September 22, 2017, we entered into an exchange agreement, or the Exchange Agreement, with Spetses and its shareholders.&#160; Under the terms of the Exchange Agreement, we issued
    2,400,000 common shares 480,000 Series A Preferred Shares and 12,000 Series B Preferred Shares of the Company in exchange for all of the issued and outstanding common shares of Spetses.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">On November 21, 2017, we declared a dividend of one preferred share purchase right for each outstanding common share and adopted a shareholder rights plan, as set forth in a
    Stockholders Rights Agreement dated as of November 20, 2017, by and between us and American Stock Transfer &amp; Trust Company, LLC, as rights agent. For more information, please see &#8220;&#8212;Stockholders Rights Agreement&#8221; herein. In connection with the
    Stockholders Rights Agreement, we designated 1,000,000 shares as Series C Participating Preferred Stock, none of which are outstanding as of the date of this prospectus.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Common Shares</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Each outstanding common share entitles the holder to one vote on all matters submitted to a vote of shareholders. Subject to preferences that may be applicable to any outstanding
    preferred shares, holders of common shares are entitled to receive ratably all dividends, if any, declared by our Board out of funds legally available for dividends. Upon our dissolution or liquidation or the sale of all or substantially all of our
    assets, after payment in full of all amounts required to be paid to creditors and to the holders of preferred stock having liquidation preferences, if any, the holders of our common shares are entitled to receive pro rata our remaining assets available
    for distribution. Holders of common shares do not have conversion, redemption or pre-emptive rights to subscribe to any of our securities. The rights, preferences and privileges of holders of our common shares are subject to the rights of the holders
    of any preferred shares, which we have issued in the past or which we may issue in the future.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Preferred Shares</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Our articles of incorporation authorize our Board to establish one or more series of preferred shares and to determine, with respect to any series of preferred shares, the terms
    and rights of that series, including:</div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z9f9c6d30e5374baaacd8e24ac9881665">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the designation of the series;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zf125337ebb214c27809a6c9598202189">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the number of shares of the series;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zf9cd522a8fad4b5ab304bff885fa98c5">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the preferences and relative, participating, option or other special rights, if any, and any qualifications, limitations or restrictions of such series; and</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z86dc636d03344a51ae1fb734ec836add">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the voting rights, if any, of the holders of the series.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Description of Series A Preferred Shares</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">On September 22, 2017, we issued 480,000 Series A Preferred Shares to the shareholders of Spetses, under the Exchange Agreement.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The Series A Preferred Shares entitle the holders thereof to receive cumulative cash dividends when, as and if declared by our Board out of legally available funds for such
    purpose.&#160; Each Series A Preferred Share has a fixed liquidation preference of $25.00 per share plus an amount equal to accumulated and unpaid dividends thereon to the date fixed for payment, whether or not declared. See &#8220;&#8212;Liquidation Rights.&#8221;</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The Series A Preferred Shares represent perpetual equity interests in us and, unlike indebtedness, will not give rise to a claim for payment of a principal amount at a particular
    date.&#160;&#160; As such, the Series A Preferred Shares will rank junior to any future indebtedness and other liabilities with respect to assets available to satisfy claims against us.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">12</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Ranking</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The Series A Preferred Shares rank, with respect to dividend distributions and distributions upon the liquidation, winding-up and dissolution of our affairs, senior to our common
    shares, our Series B Preferred Shares and to each other class or series of capital stock established after the original issue date of the Series A Preferred Shares as to the payment of dividends and amounts payable upon liquidation, dissolution or
    winding up, whether voluntary or involuntary (&#8220;Junior Stock&#8221;).</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We may issue additional common shares, additional Series A Preferred Shares and Junior Stock.&#160; Except as described in the Series A Preferred Shares Statement of Designation, the
    Board has the authority to determine the preferences, powers, qualifications, limitations, restrictions and special or relative rights or privileges, if any, of any such series of Junior Stock before the issuance of any shares of that series.&#160; The
    Board shall also determine the number of shares constitution each series of securities.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Dividends</font></div>
  <div style="text-align: justify; margin-bottom: 12pt;"><font style="font-weight: bold; font-style: italic;">General</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Holders of the Series A Preferred Shares will be entitled to receive, when, as and if declared by our Board out of legally available funds for such purpose, cumulative cash
    dividends from September 22, 2017.</div>
  <div style="text-align: justify; margin-bottom: 12pt;"><font style="font-weight: bold; font-style: italic;">Dividend Rate</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Dividends on Series A Preferred Shares are cumulative, commencing on September 22, 2017, and payable on each Dividend Payment Date, commencing December 15, 2017, when, as and if
    declared by our Board or any authorized committee thereof out of legally available funds for such purpose. Dividends on the Series A Preferred Shares accrue at a rate of 9.75% per annum per Series A Preferred Share.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">In the event that any semi-annual dividend payable on the Series A Preferred Shares is in arrears, the Dividend Rate payable on the Series A Preferred Shares increases to a rate
    that is 1.30 times the Dividend Rate payable on the Series A Preferred Shares as of the close of business on the day immediately preceding the Dividend Payment Date, and in any subsequent Dividend Payment Date the Dividend Rate payable shall increase
    to a rate that is 1.30 times the Dividend Rate payable on the Series A Preferred Shares as in effect as of the close of business on the day immediately preceding such Dividend Payment Date until Dividend Payment Default is cured.</div>
  <div style="text-align: justify; margin-bottom: 12pt;"><font style="font-weight: bold; font-style: italic;">Dividend Payment Dates</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The &#8220;Dividend Payment Dates&#8221; for the Series A Preferred Shares is June 15 and December 15, commencing December 15, 2017. Dividends will accumulate in each dividend period from and
    including the preceding Dividend Payment Date or the initial issue date, as the case may be, to but excluding the applicable Dividend Payment Date for such dividend period. If any Dividend Payment Date otherwise would fall on a day that is not a
    Business Day, declared dividends will be paid on the immediately succeeding Business Day without the accumulation of additional dividends. Dividends on the Series A Preferred Shares will be payable based on a 360-day year consisting of twelve 30-day
    months.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">&#8220;Business Day&#8221; means a day on which NASDAQ is open for trading and which is not a Saturday, a Sunday or other day on which banks in New York City are authorized or required by law
    to close.</div>
  <div style="text-align: justify; margin-bottom: 12pt;"><font style="font-weight: bold; font-style: italic;">Payment of Dividends</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Not later than the close of business, New York City time, on each Dividend Payment Date, we will pay those dividends, if any, on the Series A Preferred Shares that have been
    declared by our Board to the holders of such shares as such holders&#8217; names appear on our stock transfer books maintained by the Registrar and Transfer Agent on the applicable Record Date. The applicable record date (the &#8220;Record Date&#8221;), will be the
    Business Day immediately preceding the applicable Dividend Payment Date, except that in the case of payments of dividends in arrears, the Record Date with respect to a Dividend Payment Date will be such date as may be designated by our Board in
    accordance with our Bylaws then in effect and the Statement of Designation.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">No dividend may be declared or paid or set apart for payment on any Junior Stock (other than a dividend payable solely in shares of Junior Stock) unless full cumulative dividends
    have been or contemporaneously are being paid or provided for on all outstanding Series A Preferred Shares for all prior and the then-ending dividend periods. In addition, in the event that full cumulative dividends on the Series A Preferred Shares
    have not been paid or declared and set apart for payment, we may not repurchase, redeem or otherwise acquire, in whole or in part, any Series A Preferred Shares except pursuant to a purchase or exchange offer made on the same terms to all holders of
    Series A Preferred Shares. Common stock and any other Junior Stock may not be redeemed, repurchased or otherwise acquired unless full cumulative dividends on the Series A Preferred Shares for all prior and the then-ending dividend periods have been
    paid or declared and set apart for payment.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">13</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Accumulated dividends in arrears for any past dividend period may be declared by our Board and paid on any date fixed by our Board, whether or not a Dividend Payment Date, to
    holders of the Series A Preferred Shares on the record date for such payment, which may not be more than 60 days, nor less than 5 days, before such payment date. Subject to the next succeeding sentence, if all accumulated dividends in arrears on all
    outstanding Series A Preferred Shares have not been declared and paid, or sufficient funds for the payment thereof have not been set apart, payment of accumulated dividends in arrears will be made in order of their respective Dividend Payment Dates,
    commencing with the earliest. If less than all dividends payable with respect to all Series A Preferred Shares are paid, any partial payment will be made pro rata with respect to the Series A Preferred Shares entitled to a dividend payment at such time
    in proportion to the aggregate amounts remaining due in respect of such shares at such time. Holders of the Series A Preferred Shares will not be entitled to any dividend, whether payable in cash, property or stock, in excess of full cumulative
    dividends. No interest or sum of money in lieu of interest will be payable in respect of any dividend payment which may be in arrears on the Series A Preferred Shares.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Liquidation Rights</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The holders of outstanding Series A Preferred Shares will be entitled, in the event of any liquidation, dissolution or winding up of our affairs, whether voluntary or involuntary,
    to receive the liquidation preference of $25.00 per share in cash plus an amount equal to accumulated and unpaid dividends thereon to the date fixed for payment of such amount (whether or not declared), and no more, before any distribution will be made
    to the holders of our common stock or any other Junior Stock. A consolidation or merger of us with or into any other entity, individually or in a series of transactions, will not be deemed a liquidation, dissolution or winding up of our affairs for
    this purpose. In the event that our assets available for distribution to holders of the outstanding Series A Preferred Shares are insufficient to permit payment of all required amounts, our assets then remaining will be distributed among the Series A
    Preferred Shares, as applicable, ratably on the basis of their relative aggregate liquidation preferences. After payment of all required amounts to the holders of the outstanding Series A Preferred Shares, our remaining assets and funds will be
    distributed among the holders of the common stock and any other Junior Stock then outstanding according to their respective rights.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Voting Rights</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The Series A Preferred Shares have no voting rights except as provided by Marshall Islands law.&#160; Unless the Company shall have received the affirmative vote or consents of the
    Holders of at least two thirds of the outstanding Series A Preferred Shares, voting as a single class, the Company may not adopt any amendment to the Articles of Incorporation that adversely alters the preferences, powers or rights of the Series A
    Preferred Shares.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Redemption</font></div>
  <div style="text-align: justify; margin-bottom: 12pt;"><font style="font-weight: bold; font-style: italic;">Optional Redemption</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We have the right at any time on or after March 22, 2018 to redeem the Series A Preferred Shares, in whole or from time to time in part, from any funds available for such purpose.
    Any such redemption shall occur on a date set by the Company, or the Redemption Date.</div>
  <div style="text-align: justify; margin-bottom: 12pt;"><font style="font-weight: bold; font-style: italic;">Redemption Procedures</font></div>
  <div style="text-align: justify; text-indent: 72pt; margin-bottom: 12pt;">(a) Redemption Price. The Company may redeem each share of Series A Preferred Shares at an amount equal to $25.00 per Series A Preferred Share in cash plus an amount equal to
    accumulated and unpaid dividends as of the Redemption Date, whether or not declared, or the Redemption Price.&#160; The Redemption Price may be paid in cash, common shares or a note as shall be determined in the Company&#8217;s sole discretion.&#160; If paid in common
    shares, the price of the common shares will be 90% of the lowest daily volume weighted average price on any trading day during the 5 consecutive trading day period ending and including the trading day immediately prior to the date of the applicable
    Redemption Date.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Notwithstanding any other provisions herein, the holder of Series A Preferred Shares shall not acquire, or be obligated or have the right to acquire, any common share pursuant to
    an optional redemption which, when aggregated with all other common shares then beneficially owned (as calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder) by the Holder and its Affiliates, would result in the
    beneficial ownership by the holder of Series A Preferred Shares of more than 4.9% of the then issued and outstanding common shares, or the Ownership Limitation.&#160; If the Company issues a Redemption Notice that would cause the aggregate number of common
    shares then beneficially owned (as calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder) by the holder of Series A Preferred Shares and its affiliates to exceed the Ownership Limitation, such Redemption Notice
    shall be void ab initio to the extent of the amount by which the number of common shares otherwise issuable pursuant to such Redemption Notice, together with all common shares then beneficially owned (as calculated pursuant to Section 13(d) of the
    Exchange Act and Rule 13d-3 promulgated thereunder) by the holder of Series A Preferred Shares and its affiliates, would exceed the Ownership Limitation.&#160; Upon the written or oral request of the holder of Series A Preferred Shares, the Company shall
    promptly confirm orally or in writing to the holder of Series A Preferred Shares the number of common shares then outstanding. The holder of Series A Preferred Shares and the Company shall each cooperate in good faith in the determinations required
    hereby and the application hereof.&#160; The holder&#8217;s of Series A Preferred Shares written certification to the Company of the applicability of the Ownership Limitation, and the resulting effect thereof hereunder at any time, shall be conclusive with
    respect to the applicability thereof and such result absent manifest error. Upon delivery of a written notice to the Company, the holder of Series A Preferred Shares may from time to time increase (with such increase not effective until the sixty-first
    (61st) day after delivery of such notice) or decrease the Ownership Limitation to any other amount of common shares not in excess of 9.99% of the then issued and outstanding shares of common shares as specified in such notice; provided that any such
    increase in the Ownership Limitation will not be effective until the sixty-first (61st) day after such written notice is delivered to the Company.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">14</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 72pt; margin-bottom: 12pt;">(b) Redemption Notice. The Company shall give notice of any redemption by mail not less than 30 days and not more than 60 days before the scheduled Redemption Date, to the holder
    of Series A Preferred Shares of record (as of 4:59 p.m. New York City time on the Business Day next preceding the day on which notice is given) of any Series A Preferred Shares to be redeemed as such holders&#8217; names appear on the Company&#8217;s stock
    transfer books maintained by the Registrar and Transfer Agent and at the address of such holders shown therein. Such notice, or the Redemption Notice shall state: (1) the Redemption Date, (2) the number of Series A Preferred Shares to be redeemed and,
    if less than all outstanding Series A Preferred Shares are to be redeemed, the number (and the identification) of shares to be redeemed from such Holder, (3) the Redemption Price, (4) the place where the Series A Preferred Shares is to be redeemed and
    shall be presented and surrendered for payment of the Redemption Price therefor and (5) that dividends on the stock to be redeemed shall cease to accumulate from and after such Redemption Date.</div>
  <div style="text-align: justify; text-indent: 72pt; margin-bottom: 12pt;">(c) <font style="font-family: 'Times New Roman', serif; font-size: 1pt;">&#160; </font>Effect of Redemption; Partial Redemption. If the Company elects to redeem less than all of the
    outstanding Series A Preferred Shares, the number of shares to be redeemed shall be determined by the Company, and such shares shall be redeemed pro rata or by lot, with adjustments to avoid redemption of fractional shares.&#160; The Company shall give
    notice, or cause notice to be given, to the holders of the number of shares of Series A Preferred Shares to be redeemed, and the Company shall determine the number of Series A Preferred Shares to be redeemed from the account of each of its participants
    holding such shares in its participant account. The aggregate Redemption Price for any such partial redemption of the outstanding Series A Preferred Shares shall be allocated correspondingly among the redeemed Series A Preferred Shares. The Series A
    Preferred Shares not redeemed shall remain outstanding and subject to all the terms provided in this Statement of Designation.</div>
  <div style="text-align: justify; text-indent: 72pt; margin-bottom: 12pt;">(d) Redemption Funds. If the Company gives or causes to be given a Redemption Notice, the Company shall deposit with the paying agent funds sufficient to redeem the Series A
    Preferred Shares as to which such Redemption Notice shall have been given, no later than 4:59 p.m. New York City time on the Business Day immediately preceding the Redemption Date, and shall give the paying agent irrevocable instructions and authority
    to pay the Redemption Price to the holders of the Series A Preferred Shares to be redeemed upon surrender or deemed surrender of the certificates therefor. If the Redemption Notice shall have been given, from and after the Redemption Date, unless the
    Company defaults in providing funds sufficient for such redemption at the time and place specified for payment pursuant to the Redemption Notice, all dividends on such Series A Preferred Shares to be redeemed shall cease to accumulate and all rights of
    Holders of such shares as the Company&#8217;s shareholders shall cease, except the right to receive the Redemption Price, and such shares shall not thereafter be transferred on Company&#8217;s stock transfer books or be deemed to be outstanding for any purpose
    whatsoever. The Company shall be entitled to receive from the paying agent the interest income, if any, earned on such funds deposited with the paying agent (to the extent that such interest income is not required to pay the Redemption Price of the
    Series A Preferred Shares to be redeemed), and the holders of any shares so redeemed shall have no claim to any such interest income. Any funds deposited with the paying agent hereunder by the Company for any reason, including, but not limited to,
    redemption of Series A Preferred Shares, that remain unclaimed or unpaid after two years after the applicable Redemption Date or other payment date, shall be, to the extent permitted by law, repaid to the Company upon its written request after which
    repayment the holders of the Series A Preferred Shares entitled to such redemption or other payment shall have recourse only to the Company. Notwithstanding any Redemption Notice, there shall be no redemption of any Series A Preferred Shares called for
    redemption until funds sufficient to pay the full Redemption Price of such shares shall have been deposited by the Company with the paying agent.</div>
  <div style="text-align: justify; text-indent: 72pt; margin-bottom: 12pt;">(e) Certificate. If only a portion of the Series A Preferred Shares represented by a certificate shall have been called for redemption, upon surrender of the certificate to the
    Paying Agent, the Paying Agent shall issue to the Holder of such shares a new certificate (or adjust the applicable book-entry account) representing the number of shares of Series A Preferred Shares represented by the surrendered certificate that have
    not been called for redemption.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">15</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Description of Series B Preferred Shares</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">On September 22, 2017, we issued 12,000 Series B Preferred Shares to Thalassa, a company wholly owned and controlled by our Chairman, Chief Executive Officer and Chief Financial
    Officer, Petros Panagiotidis, under the Exchange Agreement. Each Series B Preferred Share has the voting power of one hundred thousand (100,000) common shares.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The Series B Preferred Stock has the following characteristics:</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-weight: bold; font-style: italic;">Conversion</font>. The Series B Preferred Shares are not convertible into common shares.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-weight: bold; font-style: italic;">Voting</font>. Each Series B Preferred Share has the voting power of 100,000 common shares and shall count for 100,000 votes
    for purposes of determining quorum at a meeting of shareholders.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-weight: bold; font-style: italic;">Distributions</font>. The Series B Preferred Shares shall have no dividend or distribution rights.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-weight: bold; font-style: italic;">Liquidation, Dissolution or Winding Up</font>. Upon any liquidation, dissolution or winding up of the Company, the Series B
    Preferred Shares shall have the same liquidation rights as the common shares.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Stockholders Rights Agreement</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">On November 21, 2017, our Board declared a dividend of one preferred share purchase right, or a Right, for each outstanding common share and adopted a shareholder rights plan, as
    set forth in the Stockholders Rights Agreement dated as of November 20, 2017, or the Rights Agreement, by and between the Company and American Stock Transfer &amp; Trust Company, LLC, as rights agent.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The Board adopted the Rights Agreement to protect shareholders from coercive or otherwise unfair takeover tactics. In general terms, it works by imposing a significant penalty upon
    any person or group that acquires 15% or more of our outstanding common shares without the approval of our Board. If a shareholder&#8217;s beneficial ownership of our common shares as of the time of the public announcement of the rights plan and associated
    dividend declaration is at or above the applicable threshold, that shareholder&#8217;s then-existing ownership percentage would be grandfathered, but the rights would become exercisable if at any time after such announcement, the shareholder increases its
    ownership percentage by 1% or more.&#160; Our Chairman, Chief Executive Officer and Chief Financial Officer, Petros Panagiotidis, is exempt from these provisions.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The Rights may have anti-takeover effects. The Rights will cause substantial dilution to any person or group that attempts to acquire us without the approval of our Board. As a
    result, the overall effect of the Rights may be to render more difficult or discourage any attempt to acquire us. Because our Board can approve a redemption of the Rights for a permitted offer, the Rights should not interfere with a merger or other
    business combination approved by our Board.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">For those interested in the specific terms of the Rights Agreement, we provide the following summary description. Please note, however, that this description is only a summary, and
    is not complete, and should be read together with the entire Rights Agreement, which is an exhibit to this annual report. &#160;<font style="background-color: #FFFFFF;">The foregoing description of the Rights Agreement is qualified in its entirety by
      reference to such exhibit.</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-style: italic;">The Rights</font>. The Rights trade with, and are inseparable from, our common shares. The Rights are evidenced only by certificates that
    represent our common shares. New Rights will accompany any new common shares of the Company issued after November 21, 2017 until the Distribution Date described below.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-style: italic;">Exercise Price</font>. Each Right allows its holder to purchase from the Company one one-thousandth of a share of Series C Participating Preferred
    Stock, or a Series C Preferred Share, for $15.00, or the Exercise Price, once the Rights become exercisable. This portion of a Series C Preferred Share will give the shareholder approximately the same dividend, voting and liquidation rights as would
    one common share. Prior to exercise, the Right does not give its holder any dividend, voting, or liquidation rights.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-style: italic;">Exercisability</font>. The Rights are not exercisable until ten days after the public announcement that a person or group has become an &#8220;Acquiring
    Person&#8221; by obtaining beneficial ownership of 15% or more of our outstanding common shares.&#160; Except our Chairman, Chief Executive Officer and Chief Financial Officer, Petros Panagiotidis, is exempt from being the &#8220;Acquiring Person&#8221;.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Certain synthetic interests in securities created by derivative positions &#8212; whether or not such interests are considered to be ownership of the underlying common shares or are
    reportable for purposes of Regulation 13D of the Securities Exchange Act of 1934, as amended&#8212; are treated as beneficial ownership of the number of our common shares equivalent to the economic exposure created by the derivative position, to the extent
    our actual common shares are directly or indirectly held by counterparties to the derivatives contracts. Swaps dealers unassociated with any control intent or intent to evade the purposes of the Rights Agreement are excepted from such imputed
    beneficial ownership.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">For persons who, prior to the time of public announcement of the Rights Agreement, beneficially own 15% or more of our outstanding common shares, the Rights Agreement
    &#8220;grandfathers&#8221; their current level of ownership, so long as they do not purchase additional shares in excess of certain limitations.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The date when the Rights become exercisable is the &#8220;Distribution Date.&#8221; Until that date, our common share certificates (or, in the case of uncertificated shares, by notations in
    the book-entry account system) will also evidence the Rights, and any transfer of our common shares will constitute a transfer of Rights. After that date, the Rights will separate from our common shares and will be evidenced by book-entry credits or by
    Rights certificates that the Company will mail to all eligible holders of our common shares. Any Rights held by an Acquiring Person are null and void and may not be exercised.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">16</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="background-color: #FFFFFF;">
    <div style="text-align: left; margin-top: 3pt; margin-bottom: 12pt;"><u>Series C Preferred Share Provisions</u></div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Each one one-thousandth of a Series C Preferred Share, if issued, will, among other things:</div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z07e9a1b845fc4da49e3175e1dc0df10a">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>not be redeemable;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z3c9ead070f354875b8dc11310c13b649">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>entitle holders to quarterly dividend payments in an amount per share equal to the aggregate per share amount of all cash dividends, and the aggregate per share amount (payable in kind) of all non-cash dividends or other distributions
                other than a dividend payable in our common shares or a subdivision of the our outstanding common shares (by reclassification or otherwise), declared on our common shares since the immediately preceding quarterly dividend payment date; and</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z222e854a35ef496299cc1504d782d4f4">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>entitle holders to one vote on all matters submitted to a vote of the shareholders of the Company.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The value of one one-thousandth interest in a Series C Preferred Share should approximate the value of one common share.</div>
  <div style="background-color: #FFFFFF;">
    <div style="text-align: left; margin-top: 3pt; margin-bottom: 12pt;"><u>Consequences of a Person or Group Becoming an Acquiring Person.</u></div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-style: italic;">Flip In.</font>&#160; If an Acquiring Person obtains beneficial ownership of 15% or more of our common shares, then each Right will entitle the holder
    thereof to purchase, for the Exercise Price, a number of our common shares (or, in certain circumstances, cash, property or other securities of the Company) having a then-current market value of twice the Exercise Price. However, the Rights are not
    exercisable following the occurrence of the foregoing event until such time as the Rights are no longer redeemable by the Company, as further described below.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Following the occurrence of an event set forth in preceding paragraph, all Rights that are or, under certain circumstances specified in the Rights Agreement, were beneficially
    owned by an Acquiring Person or certain of its transferees will be null and void.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-style: italic;">Flip Over.</font>&#160;If, after an Acquiring Person obtains 15% or more of our common shares, (i) the Company merges into another entity; (ii) an
    acquiring entity merges into the Company; or (iii) the Company sells or transfers 50% or more of its assets, cash flow or earning power, then each Right (except for Rights that have previously been voided as set forth above) will entitle the holder
    thereof to purchase, for the Exercise Price, a number of our common shares of the person engaging in the transaction having a then-current market value of twice the Exercise Price.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-style: italic;">Notional Shares</font>. Shares held by affiliates and associates of an Acquiring Person, including certain entities in which the Acquiring Person
    beneficially owns a majority of the equity securities, and Notional Common Shares (as defined in the Rights Agreement) held by counterparties to a Derivatives Contract (as defined in the Rights Agreement) with an Acquiring Person, will be deemed to be
    beneficially owned by the Acquiring Person.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-style: italic;">Redemption</font>. The Board may redeem t<font style="background-color: #FFFFFF;">he Rights for $0.01 per Right at any time before any person or
      group becomes an Acquiring Person. If the Board redeems any Rights, it must redeem all of the Rights. Once the Rights are redeemed, the only right of the holders of the Rights will be to receive the redemption price of $0.01 per Right. The redemption
      price will be adjusted if the Company has a stock dividend or a stock split.</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-style: italic;">Exchange.&#160;</font>After a person or group becomes an Acquiring Person, but before an Acquiring Person owns 50% or more of our outstanding common
    shares, the Board may extinguish the Rights by exchanging one common share or an equivalent security for each Right, other than Rights held by the Acquiring Person. I<font style="background-color: #FFFFFF;">n certain circumstances, the Company may
      elect to exchange the Rights for cash or other securities of the Company having a value approximately equal to one common share.</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-style: italic;">Expiration</font>.&#160;<font style="background-color: #FFFFFF;">The Rights expire on the earliest of (i) November 21, 2027; or (ii) the redemption or
      exchange of the Rights as described above.</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-style: italic;">Anti-Dilution Provisions</font>. The Board may adjust the purchase price of the Series C Preferred Shares, the number of Series C Preferred Shares
    issuable and the number of outstanding Rights to prevent dilution that may occur from a stock dividend, a stock split, or a reclassification of the Series C Preferred Shares or our common shares. No adjustments to the Exercise Price of less than 1%
    will be made.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">17</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-style: italic;">Amendments</font>.&#160;<font style="background-color: #FFFFFF;">The terms of the Rights and the Rights Agreement may be amended in any respect without
      the consent of the holders of the Rights on or prior to the Distribution Date. Thereafter, the terms of the Rights and the Rights Agreement may be amended without the consent of the holders of Rights, with certain exceptions, in order to (i) cure any
      ambiguities; (ii) correct or supplement any provision contained in the Rights Agreement that may be defective or inconsistent with any other provision therein; (iii) shorten or lengthen any time period pursuant to the Rights Agreement; or (iv) make
      changes that do not adversely affect the interests of holders of the Rights (other than an Acquiring Person or an affiliate or associate of an Acquiring Person).</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-style: italic;">Taxes.</font>&#160;The distribution of Rights should not be taxable for federal income tax purposes. However, following an event that renders the
    Rights exercisable or upon redemption of the Rights, shareholders may recognize taxable income.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Listing</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Our common shares are listed on the NASDAQ Capital Market and the NOTC under the ticker symbols &#8220;CTRM&#8221; and &#8220;CASTOR&#8221;, respectively.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Transfer agent</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The registrar and transfer agent for our common shares is American Stock Transfer &amp; Trust Company.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">18</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">DESCRIPTION OF DEBT SECURITIES</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We may offer and issue debt securities from time to time in one or more series, under one or more indentures, each dated as of a date on or prior to the issuance of the debt
    securities to which it relates, and pursuant to an applicable prospectus supplement.&#160; We may issue senior debt securities and subordinated debt securities pursuant to separate indentures, a senior indenture and a subordinated indenture, respectively,
    in each case between us and the trustee named in the indenture.&#160; We have filed forms of these documents as exhibits to the registration statement, of which this prospectus forms a part.&#160; The senior indenture and the subordinated indenture, as amended
    or supplemented from time to time, are sometimes referred to individually as an &#8220;indenture&#8221; and collectively as the &#8220;indentures.&#8221; Each indenture will be subject to and governed by the Trust Indenture Act and will be construed in accordance with and
    governed by the laws of the State of New York, without giving effect to any principles thereof relating to conflicts of law that would result in the application of the laws of any other jurisdiction, unless otherwise stated in the applicable prospectus
    supplement and indenture (or post-effective amendment hereto).&#160; The aggregate principal amount of debt securities which may be issued under each indenture will contain the specific terms of any series of debt securities or provide that those terms must
    be set forth in or determined pursuant to, an authorizing resolution, as defined in the applicable prospectus supplement, and/or a supplemental indenture, if any, relating to such series.&#160; Our debt securities may be convertible or exchangeable into any
    of our equity or other debt securities.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The following description sets forth certain general terms and provisions of the debt securities. The particular terms and provisions of the debt securities offered by any
    prospectus supplement, and the extent to which the general terms and provisions described below may apply to the offered debt securities, will be described in the applicable subsequent filings.&#160; We refer to any applicable prospectus supplement,
    amendment to the registration statement of which this prospectus forms a part, and reports we file with the Commission under the Exchange Act as &#8220;subsequent filings.&#8221;&#160; The statements below are not complete and are subject to, and are qualified in their
    entirety by reference to, all of the provisions of the applicable indenture. The specific terms of any debt securities that we may offer, including any modifications of, or additions to, the general terms described below as well as any applicable
    material U.S. federal income tax considerations concerning the ownership of such debt securities will be described in the applicable prospectus supplement and indenture and, as applicable, supplemental indenture. Accordingly, for a complete description
    of the terms of a particular issue of debt securities, the general description of the debt securities set forth below should be read in conjunction with the applicable prospectus supplement and indenture, as amended or supplemented from time to time.</div>
  <div style="background-color: #FFFFFF;">
    <div style="text-align: justify; margin-bottom: 12pt;"><font style="font-weight: bold;">General</font></div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We expect that neither indenture will limit the amount of debt securities which may be issued.&#160; The debt securities may be issued in one or more series.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">You should read the applicable indenture and subsequent filings relating to the particular series of debt securities for the following terms of the offered debt securities:</div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zc584a08436f1421d8d7f2819991f2c90">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the designation, aggregate principal amount and authorized denominations;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="ze9b6048d0c8e496ab14a625be8d527e0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the issue price, expressed as a percentage of the aggregate principal amount;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zf6edb980ccda4bb096f8e1c9fccfe6ea">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the maturity date;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z6a04f3fef2fd4d4e9a0aed9238b44056">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the interest rate per annum, if any;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z3d74dd4853824420a5b962cfa25c2cd8">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>if the debt securities provide for interest payments, the date from which interest will accrue, the dates on which interest will be payable, the date on which payment of interest will commence and the regular record dates for interest
                payment dates;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z4e099b18d5ec451ba29e7d064e9a6e35">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>any optional or mandatory sinking fund provisions or exchangeability provisions;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z784e31831bbe460f8e07e891376467d5">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the terms and conditions upon which conversion of any convertible debt securities may be effected, including the conversion price, the conversion period and other conversion provisions;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zdc33c3f6cc644d19947cb2a7fa273a3d">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>whether the debt securities will be our senior or subordinated securities;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z4b8258fb68874fc2b8ee774cf1b79f35">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>whether the debt securities will be our secured or unsecured obligations;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zc108e95cd7cf4f479c522a60b8a6cf3b">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the applicability and terms of any guarantees;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">19</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z7d1205188bf84664bb208eaa7a3481f8">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the date, if any, after which and the price or prices at which the debt securities may be optionally redeemed or must be mandatorily redeemed and any other terms and provisions of optional or mandatory redemptions;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="za3a4a9e4c1f74df78b370e9633df11da">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>if other than denominations of $1,000 and any integral multiple thereof, the denominations in which the debt securities of the series will be issuable;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z6ed950f9c798434ba60e73bac5da8ec8">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>if other than the full principal amount, the portion of the principal amount of the debt securities of the series which will be payable upon acceleration or provable in bankruptcy;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z70f3dc0528ea4719aabdd4217c3dfa62">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>any events of default not set forth in this prospectus;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zcf712ed9db454467a8c90ca17c8795e7">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the currency or currencies, including composite currencies, in which principal, premium and interest will be payable, if other than the currency of the United States of America;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z0136b6bddcb34ce784e7b12ccadc2e66">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>if principal, premium or interest is payable, at our election or at the election of any holder, in a currency other than that in which the debt securities of the series are stated to be payable, the period or periods within which, and
                the terms and conditions upon which, the election may be made;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="za92d1beacc0d4f07ae1c331369cefb83">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>whether interest will be payable in cash or additional securities at our or the holder's option and the terms and conditions upon which the election may be made;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zf05913d0d5ac41068cab13fab4b5bf56">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>if denominated in a currency or currencies other than the currency of the United States of America, the equivalent price in the currency of the United States of America for purposes of determining the voting rights of holders of those
                debt securities under the applicable indenture;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z83cb38a0415547c49bcbcb5190a7e268">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>if the amount of payments of principal, premium or interest may be determined with reference to an index, formula or other method based on a coin or currency other than that in which the debt securities of the series are stated to be
                payable, the manner in which the amounts will be determined;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z62752e82e780450c81c1358f293fb24b">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>any restrictive covenants or other material terms relating to the debt securities;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zdda7c0efd11e4aed8c8620546a02071f">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>whether the debt securities will be issued in the form of global securities or certificates in registered form;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z873d7e2a32c64b7e95b98894e9eaf786">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>any listing on any securities exchange or quotation system;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z3255c78260714217a646a8fc3ba240d7">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>additional provisions, if any, related to defeasance and discharge of the debt securities; and</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zca7716eef1924eb7815d9b794d9b5026">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>any other special features of the debt securities.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Subsequent filings may include additional terms not listed above.&#160; Unless otherwise indicated in subsequent filings with the Commission relating to the indenture, principal,
    premium and interest will be payable and the debt securities will be transferable at the corporate trust office of the applicable trustee.&#160; Unless other arrangements are made or set forth in subsequent filings or a supplemental indenture, principal,
    premium and interest will be paid by checks mailed to the registered holders at their registered addresses.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Unless otherwise indicated in subsequent filings with the Commission, the debt securities will be issued only in fully registered form without coupons, in denominations of $1,000
    or any integral multiple thereof.&#160; No service charge will be made for any transfer or exchange of the debt securities, but we may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection with these debt
    securities.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Some or all of the debt securities may be issued as discounted debt securities, bearing no interest or interest at a rate which at the time of issuance is below market rates, to be
    sold at a substantial discount below the stated principal amount.&#160; United States federal income tax consequences and other special considerations applicable to any discounted securities will be described in subsequent filings with the Commission
    relating to those securities.</div>
  <div style="background-color: #FFFFFF;">
    <div style="text-align: justify; margin-bottom: 12pt;"><font style="font-weight: bold;">Senior Debt</font></div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We may issue senior debt securities, which may be secured or unsecured, under the senior debt indenture. The senior debt securities will rank on an equal basis with all our other
    senior debt except subordinated debt.&#160; The senior debt securities will be effectively subordinated, however, to all of our secured debt to the extent of the value of the collateral securing such debt. We will disclose the amount of our debt in the
    prospectus supplement.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">20</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: left; margin-bottom: 10pt;"><font style="font-weight: bold;">Subordinated Debt</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We may issue subordinated debt securities under a subordinated debt indenture.&#160; Subordinated debt would rank subordinate and junior in right of payment, to the extent set forth in
    the subordinated debt indenture, to all our senior debt.</div>
  <div style="text-align: left; margin-bottom: 10pt;"><font style="font-weight: bold;">Covenants</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Any series of debt securities may have covenants in addition to or differing from those included in the applicable indenture which will be described in subsequent filings prepared
    in connection with the offering of such securities, limiting or restricting, among other things:</div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z30700d24a6a44f1f8ceb369b9b577ee5">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>our ability to incur either secured or unsecured debt, or both;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z0d42c35728264320a6456e463681202a">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>our ability to make certain payments, dividends, redemptions or repurchases;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="ze55449666b494f368015014efe483a8d">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>our ability to create dividend and other payment restrictions affecting our subsidiaries;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z79e2733045bc468b89377ea7c07a3679">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>our ability to make investments;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zec16ea9d4fa84028877ef0a74e1afcfa">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>mergers and consolidations by us or our subsidiaries;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z0eb4690507a14192b77582f53486eafb">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>sales of assets by us;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z5629138344c14f4b88e2df3a9c156b24">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>our ability to enter into transactions with affiliates;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zbc9b3815cec34abaaaa7ff5fcf60dabb">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>our ability to incur liens; and</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z60beda117c924cf093e479c0bc16b097">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>sale and leaseback transactions.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 10pt;"><font style="font-weight: bold;">Modification of the Indentures</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We expect that each indenture and the rights of the respective holders may be modified by us only with the consent of holders of not less than a majority in aggregate principal
    amount of the outstanding debt securities of all series under the respective indenture affected by the modification, taken together as a class.&#160; But we expect that no modification that:</div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z0e188758210d4a9181a758be089306f6">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">(1)</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>changes the amount of securities whose holders must consent to an amendment, supplement or waiver;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zeb4e8393bd264504b62fb36cf3b95c4d">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">(2)</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>reduces the rate of or changes the interest payment time on any security or alters its redemption provisions (other than any alteration to any such section which would not materially adversely affect the legal rights of any holder under
                the indenture) or the price at which we are required to offer to purchase the securities;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z2191b19afce2472f86e9befb0b2f15e9">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">(3)</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>reduces the principal or changes the maturity of any security or reduces the amount of, or postpones the date fixed for, the payment of any sinking fund or analogous obligation;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z6fe655a86d3546259ba1d5d2442ef2dd">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">(4)</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>waives a default or event of default in the payment of the principal of or interest, if any, on any security (except a rescission of acceleration of the securities of any series by the holders of at least a majority in principal amount
                of the outstanding securities of that series and a waiver of the payment default that resulted from such acceleration);</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z9b9467073146432eb4113d16a2ed4855">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">(5)</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>makes the principal of or interest, if any, on any security payable in any currency other than that stated in the security;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z9d24ca67aa5c4c0dac89c4d686185536">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">(6)</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>makes any change with respect to holders' rights to receive principal and interest, the terms pursuant to which defaults can be waived, certain modifications affecting shareholders or certain currency-related issues; or</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z20a3794b84ae42249d54075caee0c885">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">(7)</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>waives a redemption payment with respect to any security or changes any of the provisions with respect to the redemption of any securities;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 10pt;">will be effective against any holder without his consent.&#160; Other terms as specified in subsequent filings may be modified without the consent of the holders.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">21</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="background-color: #FFFFFF;">
    <div style="text-align: justify; margin-bottom: 12pt;"><font style="font-weight: bold;">Events of Default</font></div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We expect that each indenture will define an event of default for the debt securities of any series as being any one of the following events:</div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zbc5251061bf34c6899d000489ea7308d">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>default in any payment of interest when due which continues for 30 days;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zb469f8a392df467a91732b7d546d4b84">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>default in any payment of principal or premium at maturity;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z658e39870b0b4cefa814bbacc2ad9cdf">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>default in the deposit of any sinking fund payment when due;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z2286768bb366428c94b6305266ce8505">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>default in the performance of any covenant in the debt securities or the applicable indenture which</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zad28a9921b4047119c38797fa907d597">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>continues for 60 days after we receive notice of the default;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zcd8278ddde8d4714b08110235f3052d6">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>default under a bond, debenture, note or other evidence of indebtedness for borrowed money by us or our subsidiaries (to the extent we are directly responsible or liable therefor) having a principal amount in excess of a minimum amount
                set forth in the applicable subsequent filings, whether such indebtedness now exists or is hereafter created, which default shall have resulted in such indebtedness becoming or being declared due and payable prior to the date on which it
                would otherwise have become due and payable, without such acceleration having been rescinded or annulled or cured within 30 days after we receive notice of the default; and</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z32b6196c39a84fe382b56b3bf0f1c72e">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>events of bankruptcy, insolvency or reorganization.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">An event of default of one series of debt securities will not necessarily constitute an event of default with respect to any other series of debt securities.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">There may be such other or different events of default as described in an applicable subsequent filing with respect to any class or series of debt securities.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We expect that under each indenture, in case an event of default occurs and continues for the debt securities of any series, the applicable trustee or the holders of not less than
    25% in aggregate principal amount of the debt securities then outstanding of that series may declare the principal and accrued but unpaid interest of the debt securities of that series to be due and payable.&#160; Further, any event of default for the debt
    securities of any series which has been cured is expected to be permitted to be waived by the holders of a majority in aggregate principal amount of the debt securities of that series then outstanding.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We expect that each indenture will require us to file annually after debt securities are issued under that indenture with the applicable trustee a written statement signed by two
    of our officers as to the absence of material defaults under the terms of that indenture.&#160; We also expect that each indenture will provide that the applicable trustee may withhold notice to the holders of any default if it considers it in the interest
    of the holders to do so, except notice of a default in payment of principal, premium or interest.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Subject to the duties of the trustee in case an event of default occurs and continues, we expect that each indenture will provide that the trustee is under no obligation to
    exercise any of its rights or powers under that indenture at the request, order or direction of holders unless the holders have offered to the trustee reasonable indemnity.&#160; Subject to these provisions for indemnification and the rights of the trustee,
    each indenture is expected to provide that the holders of a majority in principal amount of the debt securities of any series then outstanding have the right to direct the time, method and place of conducting any proceeding for any remedy available to
    the trustee or exercising any trust or power conferred on the trustee as long as the exercise of that right does not conflict with any law or the indenture.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">22</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="background-color: #FFFFFF;">
    <div style="text-align: justify; margin-bottom: 12pt;"><font style="font-weight: bold;">Defeasance and Discharge</font></div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The terms of each indenture are expected to provide us with the option to be discharged from any and all obligations in respect of the debt securities issued thereunder upon the
    deposit with the trustee, in trust, of money or U.S. government obligations, or both, which through the payment of interest and principal in accordance with their terms will provide money in an amount sufficient to pay any installment of principal,
    premium and interest on, and any mandatory sinking fund payments in respect of, the debt securities on the stated maturity of the payments in accordance with the terms of the debt securities and the indenture governing the debt securities.&#160; We expect
    that this right may only be exercised if, among other things, we have received from, or there has been published by, the United States Internal Revenue Service a ruling to the effect that such a discharge will not be deemed, or result in, a taxable
    event with respect to holders.&#160; This discharge would not apply to our obligations to register the transfer or exchange of debt securities, to replace stolen, lost or mutilated debt securities, to maintain paying agencies and hold moneys for payment in
    trust.</div>
  <div style="background-color: #FFFFFF;">
    <div style="text-align: justify; margin-bottom: 12pt;"><font style="font-weight: bold;">Defeasance of Certain Covenants</font></div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We expect that the terms of the debt securities provide us with the right not to comply with specified covenants and that specified events of default described in a subsequent
    filing will not apply provided we deposit with the trustee money or U.S. government obligations, or both, which through the payment of interest and principal will provide money in an amount sufficient to pay any installment of principal, premium, and
    interest on, and any mandatory sinking fund payments in respect of, the debt securities on the stated maturity of such payments in accordance with the terms of the debt securities and the indenture governing such debt securities. We expect that to
    exercise this right, we will also be required to deliver to the trustee an opinion of counsel to the effect that the deposit and related covenant defeasance should not cause the holders of such series to recognize income, gain or loss for federal
    income tax purposes.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We refer you to applicable subsequent filings with respect to any deletions or additions or modifications from the description contained in this prospectus.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Form of Debt Securities</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Each debt security will be represented either by a certificate issued in definitive form to a particular investor or by one or more global securities representing the entire
    issuance of securities. Both certificated securities in definitive form and global securities may be issued either in registered form, where our obligation runs to the holder of the security named on the face of the security, or in bearer form, where
    our obligation runs to the bearer of the security.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Definitive securities name you or your nominee as the owner of the security, other than definitive bearer securities, which name the bearer as owner, and in order to transfer or
    exchange these securities or to receive payments other than interest or other interim payments, you or your nominee must physically deliver the securities to the trustee, registrar, paying agent or other agent, as applicable.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Global securities name a depositary or its nominee as the owner of the debt securities represented by these global securities, other than global bearer securities, which name the
    bearer as owner. The depositary maintains a computerized system that will reflect each investor&#8217;s beneficial ownership of the securities through an account maintained by the investor with its broker/dealer, bank, trust company or other representative,
    as we explain more fully below.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Global Securities</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We may issue the debt securities in the form of one or more fully registered global securities that will be deposited with a depositary or its nominee identified in the applicable
    prospectus supplement and registered in the name of that depositary or nominee. In those cases, one or more registered global securities will be issued in a denomination or aggregate denominations equal to the portion of the aggregate principal or face
    amount of the securities to be represented by registered global securities. Unless and until it is exchanged in whole for securities in definitive registered form, a registered global security may not be transferred except as a whole by and among the
    depositary for the registered global security, the nominees of the depositary or any successors of the depositary or those nominees. If not described below, any specific terms of the depositary arrangement with respect to any debt securities to be
    represented by a registered global security will be described in the prospectus supplement relating to those debt securities. We anticipate that the following provisions will apply to all depositary arrangements:</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Ownership of beneficial interests in a registered global security will be limited to persons, called participants, that have accounts with the depositary or persons that may hold
    interests through participants. Upon the issuance of a registered global security, the depositary will credit, on its book-entry registration and transfer system, the participants&#8217; accounts with the respective principal or face amounts of the
    securities beneficially owned by the participants. Any dealers, underwriters or selling agents participating in the distribution of the securities will designate the accounts to be credited. Ownership of beneficial interests in a registered global
    security will be shown on, and the transfer of ownership interests will be effected only through, records maintained by the depositary, with respect to interests of participants, and on the records of participants, with respect to interests of persons
    holding through participants. The laws of some jurisdictions may require that some purchasers of securities take physical delivery of these securities in definitive form. These laws may impair your ability to own, transfer or pledge beneficial
    interests in registered global securities. So long as the depositary, or its nominee, is the registered owner of a registered global security, that depositary or its nominee, as the case may be, will be considered the sole owner or holder of the
    securities represented by the registered global security for all purposes under the indenture.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Except as described below, owners of beneficial interests in a registered global security will not be entitled to have the securities represented by the registered global security
    registered in their names, will not receive or be entitled to receive physical delivery of the securities in definitive form and will not be considered the owners or holders of the securities under the indenture. Accordingly, each person owning a
    beneficial interest in a registered global security must rely on the procedures of the depositary for that registered global security and, if that person is not a participant, on the procedures of the participant through which the person owns its
    interest in that registered global security, to exercise any rights of a holder under the indenture. We understand that under existing industry practices, if we request any action of holders of a registered global security or if an owner of a
    beneficial interest in a registered global security desires to give or take any action that a holder is entitled to give or take under the indenture, the depositary for the registered global security would authorize the participants holding the
    relevant beneficial interests to give or take that action, and the participants would authorize beneficial owners owning through them to give or take that action or would otherwise act upon the instructions of beneficial owners holding through them.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">23</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Principal, premium, if any, and interest payments on debt securities represented by a registered global security registered in the name of a depositary or its nominee will be made
    to the depositary or its nominee, as the case may be, as the registered owner of the registered global security. None of us, the trustee or any other agent of us or agent of the trustee will have any responsibility or liability to owners of beneficial
    interests for any aspect of the records relating to payments made on account of beneficial ownership interests in the registered global security or for maintaining, supervising or reviewing any records relating to those beneficial ownership interests.
    We expect that the depositary for any of the securities represented by a registered global security, upon receipt of any payment of principal, premium, interest or other distribution of underlying securities or other property to holders on that
    registered global security, will immediately credit participants&#8217; accounts in amounts proportionate to their respective beneficial interests in that registered global security as shown on the records of the depositary. We also expect that payments by
    participants to owners of beneficial interests in a registered global security held through participants will be governed by standing customer instructions and customary practices, as is now the case with the securities held for the accounts of
    customers in bearer form or registered in &#8220;street name,&#8221; and will be the responsibility of those participants.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We expect that the indenture will provide that if the depositary for any of these securities represented by a registered global security is at any time unwilling or unable to
    continue as depositary or ceases to be a clearing agency registered under the Exchange Act, and a successor depositary registered as a clearing agency under the Exchange Act is not appointed by us within 90 days, we will be required to issue securities
    in definitive form in exchange for the registered global security that had been held by the depositary. In addition, the indenture is expected to allow us to decide, at any time and in our sole discretion, to not have any of the securities represented
    by one or more registered global securities. If we make that decision, we will issue securities in definitive form in exchange for all of the registered global security or securities representing those securities. Any securities issued in definitive
    form in exchange for a registered global security will be registered in the name or names that the depositary gives to the relevant trustee or other relevant agent of ours or theirs. It is expected that the depositary&#8217;s instructions will be based upon
    directions received by the depositary from participants with respect to ownership of beneficial interests in the registered global security that had been held by the depositary.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">In the event that the Depository Trust Company, or DTC, acts as depository for the global securities of any series, the global securities will be issued as fully registered
    securities registered in the name of Cede &amp; Co., as DTC's nominee.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">24</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">DESCRIPTION OF WARRANTS</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We may issue warrants to purchase any of our debt or equity securities. Warrants may be issued independently or together with any other securities and may be attached to, or
    separate from, such securities. Each series of warrants will be issued under a separate warrant agreement to be entered into between us and a warrant agent. The terms of any warrants to be issued and a description of the material provisions of the
    applicable warrant agreement will be set forth in the applicable prospectus supplement. We expect that such terms will include, among others:</div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z9607760c11fe4d5d9113633ef4fb4f32">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the title of such warrants;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z05a49370c78e4e6292bdbc5c318089ed">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the aggregate number of such warrants;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="ze15a0bf03ed64876aa9f4d1b116c081f">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the price or prices at which such warrants will be issued;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zf3d4a30c02de457caf3b8191092a07fc">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the number and type of our securities purchasable upon exercise of such warrants;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="ze68566a5a5a0430fbb48fa55f9a0c96d">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the price at which our securities purchasable upon exercise of such warrants may be purchased;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z2e9ade8558ee46ed9cf1a3b421b235f4">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the date on which the right to exercise such warrants shall commence and the date on which such right shall expire;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z0e8ae1946c1e4e7fb23e08e91d55783f">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>if applicable, the minimum or maximum amount of such warrants which may be exercised at any one time;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zca520e9db0264b228e405148cc809fa7">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>if applicable, the designation and terms of the securities with which such warrants are issued and the number of such warrants issued with each such security;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z6c518849519445fb988c8b7a892a5563">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>if applicable, the date on and after which such warrants and the related securities will be separately transferable;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z48d6f9acb76d40c9b129375370abc6f5">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>information with respect to book-entry procedures, if any;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z91962d47f54641cc8aa02cc89ce797c5">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>if applicable, a discussion of any material U.S. federal income tax considerations; and</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z406ae610ee2741a3a5d3944c0176a448">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>any other terms of such warrants, including terms, procedures and limitations relating to the exchange and exercise of such warrants.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">25</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">DESCRIPTION OF PURCHASE CONTRACTS</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We may issue purchase contracts for the purchase or sale of any of our debt or equity securities issued by us.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Each purchase contract will entitle the holder thereof to purchase or sell, and obligate us to sell or purchase, on specified dates, such securities at a specified purchase price,
    which may be based on a formula, all as set forth in the applicable prospectus supplement. We may, however, satisfy our obligations, if any, with respect to any purchase contract by delivering the cash value of such purchase contract or the cash value
    of the securities otherwise deliverable, as set forth in the applicable prospectus supplement. The applicable prospectus supplement will also specify the methods by which the holders may purchase or sell such securities and any acceleration,
    cancellation or termination provisions, provisions relating to U.S. federal income tax considerations, if any, or other provisions relating to the settlement of a purchase contract.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The purchase contracts may require us to make periodic payments to the holders thereof or vice versa, which payments may be deferred to the extent set forth in the applicable
    prospectus supplement, and those payments may be unsecured or pre-funded on some basis. The purchase contracts may require the holders thereof to secure their obligations in a specified manner to be described in the applicable prospectus supplement.
    Alternatively, purchase contracts may require holders to satisfy their obligations thereunder when the purchase contracts are issued. Our obligation to settle such pre-paid purchase contracts on the relevant settlement date may constitute indebtedness.
    Accordingly, pre-paid purchase contracts will be issued under either the senior indenture or the subordinated indenture.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">26</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">DESCRIPTION OF RIGHTS</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We may issue rights to purchase our equity securities. These rights may be issued independently or together with any other security offered by this prospectus and may or may not be
    transferable by the shareholder receiving the rights in the rights offering. In connection with any rights offering, we may enter into a standby underwriting agreement with one or more underwriters pursuant to which the underwriter will purchase any
    securities that remain unsubscribed for upon completion of the rights offering.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The applicable prospectus supplement relating to any rights will describe the terms of the offered rights, including, where applicable, the following:</div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z36bde5c7339948ecb8265e640946ef99">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the exercise price for the rights;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z570402dfbcd14f45a69fd282be41d539">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the number of rights issued to each shareholder;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z126295d09e594a28b14b884db2b4ccbc">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the extent to which the rights are transferable;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z020d35c18f2e4606ad0a9fa9db3a8d2f">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>any other terms of the rights, including terms, procedures and limitations relating to the exchange and exercise of the rights;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="ze5468c2b3f4e44718754c74dde6899d6">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the date on which the right to exercise the rights will commence and the date on which the right will expire;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z069035a66d2c40af9267c9527fbbdddb">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the amount of rights outstanding;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z98db2dddf5b946a6a602290e11b9897a">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the extent to which the rights include an over-subscription privilege with respect to unsubscribed securities; and</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="ze31ec78c07064fd4a4bc3de24119b283">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the material terms of any standby underwriting arrangement entered into by us in connection with the rights offering.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="background-color: #FFFFFF;">The description in the applicable prospectus supplement of any rights we offer will not necessarily be complete and will be qualified in
      its entirety by reference to the applicable rights certificate or rights agreement, which will be filed with the Commission if we offer rights. For more information on how you can obtain copies of any rights certificate or rights agreement if we
      offer rights, see the section entitled &#8220;Where You Can Find Additional Information&#8221; of this prospectus. We urge you to read the applicable rights certificate, the applicable rights agreement and any applicable prospectus supplement in their entirety.</font></div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">27</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">DESCRIPTION OF UNITS</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">As specified in the applicable prospectus supplement, we may issue units consisting of one or more rights, purchase contracts, warrants, debt securities, preferred shares, common
    shares or any combination of such securities.&#160; The applicable prospectus supplement will describe the terms of the offered units.&#160; We expect that such terms will include, among others:</div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z1249c8a560c74232b80a4fabec6afc24">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>the terms of the units and of the rights, purchase contracts, warrants, debt securities, preferred shares and common shares comprising the units, including whether and under what circumstances the securities comprising the units may be
                traded separately;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z03dfe574357a471c92779f68e47f0dd0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>a description of the terms of any unit agreement governing the units;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z80faa8956eea40e4967b04b69d13bca2">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>if applicable, a discussion of any material U.S. federal income tax considerations; and</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z5f84bddde1574b359156ab20ab9e4731">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>a description of the provisions for the payment, settlement, transfer or exchange of the units.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">28</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: center; margin-bottom: 24pt;"><font style="font-weight: bold;">EXPENSES</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The following are the estimated expenses of the issuance and distribution of the securities being registered under the registration statement of which this prospectus forms a part,
    all of which will be paid by us.</div>
  <table cellspacing="0" cellpadding="0" id="z1d1ab8cc3eec4f00849474b20de92704" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
          <div>
            <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;">SEC registration fee</div>
          </div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
        <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
          <div>
            <div>$</div>
          </div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
          <div>
            <div>12,120</div>
          </div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #FFFFFF;">
          <div>
            <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;">Printing and engraving expenses</div>
          </div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
        <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">$</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;">
          <div>
            <div>*</div>
          </div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
          <div>
            <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;">Legal fees and expenses</div>
          </div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
        <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
          <div>
            <div>*</div>
          </div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #FFFFFF;">
          <div>
            <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;">FINRA fee</div>
          </div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
        <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">$</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;">
          <div>
            <div>*</div>
          </div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
          <div>
            <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;">NASDAQ Supplemental Listing Fee</div>
          </div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
        <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
          <div>
            <div>*</div>
          </div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #FFFFFF;">
          <div>
            <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;">Accounting fees and expenses</div>
          </div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
        <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">$</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;">
          <div>
            <div>*</div>
          </div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
          <div>
            <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;">Miscellaneous</div>
          </div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
        <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
          <div>
            <div>*</div>
          </div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #FFFFFF;">
          <div>
            <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;">Total</div>
          </div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
        <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">$</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;">
          <div>
            <div>*</div>
          </div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
      </tr>

  </table>
  <div><br>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zbea2e1096d1d425a96e7448b0ab84a83">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">*</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>To be provided by a prospectus supplement or as an exhibit to a report on Form 6-K that is incorporated by reference into this registration statement.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">LEGAL MATTERS</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The validity of the securities offered by this prospectus will be passed upon for us by Seward &amp; Kissel LLP, New York, New York with respect to matters of United States and
    Marshall Islands law.</div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">EXPERTS</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The consolidated financial statements, incorporated in this Prospectus by reference from the Company&#8217;s Annual Report on Form 20-F, for the year ended September 30,2018 have been
    audited by Deloitte Certified Public Accountants S.A., an independent registered public accounting firm, as stated in their report, which is incorporated herein by reference. Such consolidated financial statements have been so incorporated in reliance
    upon the report of such firm given upon their authority as experts in accounting and auditing. The offices of Deloitte Certified Public Accountants S.A. are located at Fragoklissias 3a &amp; Granikou Street, Maroussi, Athens 151 24, Greece.</div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">WHERE YOU CAN FIND ADDITIONAL INFORMATION</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">As required by the Securities Act, we filed a registration statement relating to the securities offered by this prospectus with the Commission. This prospectus is a part of that
    registration statement, which includes additional information.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold; font-style: italic;">Government Filings</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We file annual and special reports with the Commission. You may read and copy any document that we file at the public reference room maintained by the Commission at 100 F Street,
    N.E., Washington, D.C. 20549. You may obtain information on the operation of the public reference room by calling 1 (800) SEC-0330. The Commission maintains a website (http://www.sec.gov) that contains reports, proxy and information statements and
    other information regarding registrants that file electronically with the Commission.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">This prospectus and any prospectus supplement are part of a registration statement that we filed with the Commission and do not contain all of the information in the registration
    statement. The full registration statement may be obtained from the Commission or us, as indicated below. Forms of the indenture and other documents establishing the terms of the offered securities are filed as exhibits to the registration statement.
    Statements in this prospectus or any prospectus supplement about these documents are summaries and each statement is qualified in all respects by reference to the document to which it refers. You should refer to the actual documents for a more complete
    description of the relevant matters. You may inspect a copy of the registration statement at the Commission's Public Reference Room in Washington, D.C., as well as through the Commission's website.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">29</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold; font-style: italic;">Information Incorporated by Reference</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The Commission allows us to &#8220;incorporate by reference&#8221; information that we file with it. This means that we can disclose important information to you by referring you to those
    filed documents. The information incorporated by reference is considered to be a part of this prospectus, and information that we file later with the Commission prior to the termination of this offering will also be considered to be part of this
    prospectus and will automatically update and supersede previously filed information, including information contained in this document.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We incorporate by reference the documents listed below:</div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z32108d8bd2a54c9fa223f841669d7cbc">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>Current Report on Form 6-K dated June 4, 2019, which includes the unaudited condensed consolidated interim financial statements and related Management's Discussion and Analysis of Financial Condition and Results of Operations of the
                Company for the six months ended March 31, 2019.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zc25bbed74ba048bbba5ce61a3a2e2d70">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>The description of the preferred share purchase rights set forth in our Registration Statement on Form 8-A, filed with the Commission March 21, 2019.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zdbf860261ce5447ea480577d9f831bc1">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>The description of our common share set forth in our Registration Statement on Form 8-A, filed with the Commission on February 6, 2019, as amended.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z91c44e364ad14233b16364bb8ce4b960">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>Annual Report on Form 20-F for the year ended Annual Report on Form 20-F for the year ended September 30, 2018, as amended, filed with the Commission on January 31, 2019.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zfe6d60d3ae0f4cedb105031fb643221f">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-family: Symbol, serif;">&#183;</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div>Exhibits 3.3, 3.4 and 3.5 of the Form F-4 Registration Statement declared effective on May 2, 2018, which contain the Statements of Designations of the Series A, Series B and Series C Preferred Shares of the Company, respectively.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We are also incorporating by reference all subsequent annual reports on Form 20-F that we file with the Commission and certain reports on Form 6-K that we furnish to the Commission
    after the date of this prospectus (if they state that they are incorporated by reference into this prospectus) until we file a post-effective amendment indicating that the offering of the securities made by this prospectus has been terminated. In all
    cases, you should rely on the later information over different information included in this prospectus or any prospectus supplement.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">You should rely only on the information contained or incorporated by reference in this prospectus and subsequent filings. We have not, and any underwriters have not, authorized any
    other person to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We are not, and the underwriters are not, making an offer to sell these securities in any jurisdiction
    where the offer or sale is not permitted. You should assume that the information appearing in this prospectus and any accompanying prospectus supplement as well as the information we previously filed with the Commission and incorporated by reference,
    is accurate as of the dates on the front cover of those documents only. Our business, financial condition and results of operations and prospects may have changed since those dates.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">You may request a free copy of the above mentioned filings or any subsequent filing we incorporated by reference to this prospectus by oral or written request to the following
    address:</div>
  <div style="text-align: center;">Castor Maritime Inc.</div>
  <div style="text-align: center;">Attn: Petros Panagiotidis</div>
  <div style="text-align: center;">Christodoulou Chatzipavlou 223</div>
  <div style="text-align: center;">Hawaii Royal Gardens, Apart. 16</div>
  <div style="text-align: center;">3036 Limassol</div>
  <div style="text-align: center;">Cyprus</div>
  <div style="text-align: center;">+ 357 25 357 767</div>
  <div style="text-align: center; margin-bottom: 12pt;">www.castormaritime.com</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">30</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Information provided by the Company</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">We will furnish holders of our common shares with annual reports containing audited financial statements and a report by our independent registered public accounting firm. The
    audited financial statements will be prepared in accordance with United States generally accepted accounting principles and those reports will include a &#8220;Management's Discussion and Analysis of Financial Condition and Results of Operations&#8221; section for
    the relevant periods. As a &#8220;foreign private issuer,&#8221; we are exempt from the rules under the Securities Exchange Act prescribing the furnishing and content of proxy statements to shareholders. While we intend to furnish proxy statements to any
    shareholder in accordance with the rules of the NASDAQ, those proxy statements are not expected to conform to Schedule 14A of the proxy rules promulgated under the Exchange Act. In addition, as a &#8220;foreign private issuer,&#8221; we are exempt from the rules
    under the Exchange Act relating to short swing profit reporting and liability.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-weight: bold;">Disclosure of Commission Position on Indemnification for Securities Act Liabilities</font></div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the registrant pursuant to the foregoing
    provisions, the registrant has been informed that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is therefore unenforceable.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">31</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">PART II</font></div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">INFORMATION NOT REQUIRED IN THE PROSPECTUS</font></div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z968888a0560946b38b74b046f95443d1">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;"><font style="font-weight: bold;">Item 8.</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div><font style="font-weight: bold;">Indemnification of Directors and Officers</font></div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">I. Article VIII of the Bylaws of the Registrant provides as follows:</div>
  <div style="text-align: justify; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zbfab72ddd2f148038018e9afe0400674">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Any person who is or was a Director or officer of the Corporation, or is or was serving at the request of the Corporation as a director or officer of another, partnership, joint venture, trust or other enterprise shall be entitled to be
                indemnified by the Corporation upon the same terms, under the same conditions, and to the same extent as authorized by Section 60 of the BCA, if he or she acted in good faith and in a manner he or she reasonably believed to be in or not
                opposed to the best interests of the Corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. The Corporation shall have the power to pay in advance expenses a
                director or officer incurred while defending a civil or criminal proceeding, provided that the director or officer will repay the amount if it shall ultimately be determined that he or she is not entitled to indemnification under this
                section. Any repeal or modification of this Article VIII shall not adversely affect any rights to indemnification and to the advancement of expenses of a Director or officer of the Corporation existing at the time of such repeal or
                modification with respect to any acts or omissions occurring prior to such repeal or modification.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: justify; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z479db8cf455a4cf5aaf2609dd1256039">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Corporation shall have the power to purchase and maintain insurance on behalf of any person who is or was a Director or officer of the Corporation or is or was serving at the request of the Corporation as a director or officer
                against any liability asserted against such person and incurred by such person in such capacity whether or not the Corporation would have the power to indemnify such person against such liability by law or under the provisions of these
                Bylaws.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">II. Section 60 of the Associations Law of the Republic of the Marshall Islands provides as follows:</div>
  <div style="text-align: justify; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zc90d2e9cf6504f779f3e88b7a1b2e7f7">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-style: italic;">Actions not by or in right of the corporation.</font> A corporation shall have power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or
                completed action, suit or proceeding whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation) by reason of the fact that he is or was a director or officer of the corporation, or
                is or was serving at the request of the corporation as a director or officer of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys' fees), judgments, fines and amounts paid in
                settlement actually and reasonably incurred by him in connection with such action, suit or proceeding if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the corporation, and,
                with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of no contest, or
                its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which he reasonably believed to be in or not opposed to the bests interests of the corporation, and, with respect to any
                criminal action or proceedings, had reasonable cause to believe that his conduct was unlawful.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: justify; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z2b7c33da64a44ef6afa9bd485d3ef3d3">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-style: italic;">Actions by or in right of the corporation.</font> A corporation shall have the power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or
                completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that he is or was a director or officer of the corporation, or is or was serving at the request of the corporation, or
                is or was serving at the request of the corporation as a director or officer of another corporation, partnership, joint venture, trust or other enterprise against expenses (including attorneys' fees) actually and reasonably incurred by him
                or in connection with the defense or settlement of such action or suit if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the corporation and except that no indemnification
                shall be made in respect of any claims, issue or matter as to which such person shall have been adjudged to be liable for negligence or misconduct in the performance of his duty to the corporation unless and only to the extent that the
                court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for
                such expenses which the court shall deem proper.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: justify; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z2327a2ea869846d29b31408209e9c88d">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-style: italic;">When director or officer successful.</font> To the extent that a director or officer of a corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding referred
                to in subsections (1) or (2) of this section, or in the defense of a claim, issue or matter therein, he shall be indemnified against expenses (including attorneys' fees) actually and reasonably incurred by him in connection therewith.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">32</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: justify; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z307f53cfb90c4aebbbbc52540bc49234">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-style: italic;">Payment of expenses in advance.</font> Expenses incurred in defending a civil or criminal action, suit or proceeding may be paid in advance of the final disposition of such action, suit or proceeding as
                authorized by the Board in the specific case upon receipt of an undertaking by or on behalf of the director or officer to repay such amount if it shall ultimately be determined that he is not entitled to be indemnified by the corporation as
                authorized in this section.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: justify; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z517b857740304d1dbb158a059cfc856b">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-style: italic;">Indemnification pursuant to other rights.</font> The indemnification and advancement of expenses provided by, or granted pursuant to, the other subsections of this section shall not be deemed exclusive
                of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any bylaw, agreement, vote of shareholders or disinterested directors or otherwise, both as to action in his official capacity and
                as to action in another capacity while holding such office.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: justify; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z87aa3cb2f0d848e2aaddab87dd909058">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">6.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-style: italic;">Continuation of indemnification.</font> The indemnification and advancement of expenses provided by, or granted pursuant to, this section shall, unless otherwise provided when authorized or ratified,
                continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the heirs, executors and administrators of such a person.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: justify; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zd0a9240cb51d4e3c8d4d5c503ebb8a44">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">7.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-style: italic;">Insurance.</font> A corporation shall have the power to purchase and maintain insurance on behalf of any person who is or was a director or officer of the corporation or is or was serving at the request
                of the corporation as a director or officer against any liability asserted against him and incurred by him in such capacity whether or not the corporation would have the power to indemnify him against such liability under the provisions of
                this section.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z5c8e9584432542f6bc57e8ecbfe22957">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;"><font style="font-weight: bold;">Item 9.</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div><font style="font-weight: bold;">Exhibits</font></div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">The exhibit index at the end of this registration statement, or the Exhibit Index, identifies the exhibits which are included in this registration statement and are incorporated
    herein by reference.</div>
  <div style="text-align: left; margin-bottom: 12pt;">
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="z130e29d438d6411f812e936fc8a4e2b7">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;"><font style="font-weight: bold;">Item 10.</font></td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div><font style="font-weight: bold;">Undertakings</font></div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(a) The undersigned registrant hereby undertakes:</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which,
    individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of
    securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the
    aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information
    in the registration statement. Provided, however, that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) of this section do not apply if the registration statement is on Form S-3 or Form F-3 and the information required to be included in a
    post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the
    registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(2) That, for the purpose of determining any liability under the Securities Act of 1933, as amended, each such post-effective amendment shall be deemed to be a new registration
    statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">33</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(4) To file a post-effective amendment to the registration statement to include any financial statements required by Item 8.A. of Form 20-F at the start of any delayed offering or
    throughout a continuous offering. Financial statements and information otherwise required by Section 10(a)(3) of the Act need not be furnished, <font style="font-style: italic;">provided</font>, that the registrant includes in the prospectus, by means
    of a post-effective amendment, financial statements required pursuant to this paragraph (a)(4) and other information necessary to ensure that all other information in the prospectus is at least as current as the date of those financial statements.
    Notwithstanding the foregoing, with respect to registration statements on Form F-3, a post-effective amendment need not be filed to include financial statements and information required by Section 10(a)(3) of the Securities Act of 1933 or Rule 3-19 of
    Regulation S-X if such financial statements and information are contained in periodic reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are
    incorporated by reference in the Form F-3.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(5) That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(i) If the registrant is relying on Rule 430B:</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(A) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of this Registration Statement as of the date the filed prospectus was deemed part
    of and included in this Registration Statement; and</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(B) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made
    pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date
    such form of prospectus is first used after effectiveness or the date of the first contract of sale of 314 securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at
    that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time
    shall be deemed to be the initial bona fide offering thereof. <font style="font-style: italic;">Provided, however,</font> that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document
    incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any
    statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(6) That, for the purpose of determining liability of the Registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the Securities, the
    undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this Registration Statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are
    offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(iii) The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on
    behalf of the undersigned registrant; and</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(b) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant's annual report
    pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by
    reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(c) &#8212; (d) Not applicable.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(e) The undersigned registrant hereby undertakes to deliver or cause to be delivered with the prospectus, to each person to whom the prospectus is sent or given, the latest annual
    report to security holders that is incorporated by reference in the prospectus and furnished pursuant to and meeting the requirements of Rule 14a-3 or Rule 14c-3 under the Securities Exchange Act of 1934; and, where interim financial information
    required to be presented by Article 3 of Regulation S-X is not set forth in the prospectus, to deliver, or cause to be delivered to each person to whom the prospectus is sent or given, the latest quarterly report that is specifically incorporated by
    reference in the prospectus to provide such interim financial information.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">34</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(f) &#8212; (g) Not applicable.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(h) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant
    to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the
    event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or
    proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a
    court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(i) Not applicable.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(j) The undersigned registrant hereby undertakes to file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of Section 310 of
    the Trust Indenture Act in accordance with the rules and regulations prescribed by the Commission under Section 305(b)(2) of the Trust Indenture Act.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;">(k) &#8212; (l) Not applicable.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">35</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;"><a name="poa2"><!--Anchor--></a></font></div>
  <div><br>
  </div>
  <br>
  <div style="text-align: center; font-weight: bold;">$2,850,000</div>
  <div style="text-align: center; font-weight: bold;"><br>
  </div>
  <div><br>
  </div>
  <div style="text-align: center;"><img width="273" height="165" src="image00003.jpg"></div>
  <div><br>
  </div>
  <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">Common Shares<br>
  </div>
  <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;"><font style="font-style: italic;">Prospectus Supplement</font><br>
  </div>
  <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;"> <br>
  </div>
  <br>
  <div style="text-align: center; font-weight: bold;">Maxim Group LLC</div>
  <br>
  <div><br>
  </div>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;"><a name="poa"><!--Anchor--></a></font></div>
  <br>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image00003.jpg
<TEXT>
begin 644 image00003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0S!WL# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HI"<4 T +129HS0*XM%%% PHHIN[FBX#J:QP*1I HR:RK_ %F*V7+$5+DD
M7&#EL:RMFG5S-OXE@D; 85M6UZEP!@BDIIE2HRBKM%RBC-%69!1110 4444
M%%%% !12;N:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0C-'
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS5^*ZCDZ&MU(\YTY+H3TF#3LY%%4F9.(@I:*,4PL+1112*&D&E%+10 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M==::M%<*""*OG3/,JX:4&:E%1K*K#@BGY]Z:DCG:%HI**=Q"TF:6BF 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY,MNF?2NNG*Y\?F%#EE=&GBE%,R2:&R.E;IGD<MB2BD7.*6F,**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD?/RHM,[0-FGU5M91*@85:K0QDK,****"0HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<4)'GFI <<5#=C3ENB$J11]VI&--,=)NY/*Q.&I5'/-)MQ1G=Q2&G84]:4@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+>-!P*?P*44;<T['/S7W%%+1132$%%%%, HHHH **** "BBB@ J-CGI2D^E
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\T^J1A)MNX44451(AH%+10 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !113=PH; =3&-.R#44TJQ+EC4-L:5]!/?-03WR0H26'%
M86K>);>T5AO Q[UYOKWCG(98I?UK.<T=U'!RF]3J_$'C6*T+(&''O7E^N>,G
MO&*HYYKF=5UJ>\F)+$YJ"P@\^0;N>:Q<CV:6"C%%R*SN=1GW;F(-=GH7AG:5
M,B9^M3^'M)&$;;Q7H-G:Q0QY(' IVN744:8FEZ3;11J#$H(]JT[B\M-.B.57
M@5SNK:]#81MM< CWKS;7/&,EPS(DG7WJD[+0X^3VD_>V.H\1^-8T#)&<?2N
MGFO-;FS'(V":JVUI=ZI<Y()!->G>$_">Q%,D?Z5*39I/E@M#F]"\$7$TBO("
M<^M>J:%X8@M(E#Q D>U=%I^DPP1+A0#6@5CB%7R=3RJF(;=D5HM.MD48B4?A
M3WAMH4W;5&*J7^L06JG+ 5P^N>+U1'V2?K2O8FG0J5&=+JFN6]HIP5&*\T\0
M>,=Q=$?]:Y/6_%4\[,%D/YUS,EW+<-ECDUE*=SW<+@DC1O\ 59KES\Y.:SMC
MN<DYH4?WJ=DCZ5E*1[5&C&+U%"A:7>","DW@T"-I#A.M9I.YUU)QBM"*0D&I
M+='F;:%)K9TO0+B[=<H3GVKTC0/ R?*TD7Z5O"!X^)QD8K<\]L/"L][(K!3C
MZ5W>D>!& 4LGZ5Z+8>&K>V P@'X5O0V4<:C KHC3/ KX]MZ'/:1X9@MH@&B&
M1[5T$-A!$/EC JTJA>E+6ZBD>;.K*3&",+T&*=2TQLU21FV*32 TH'% XJ61
MK<6EI*6FB@I"<&EI,4P%HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "D-+28H$QAI <4_%-QS5&;3N*0
M'&*QM2T5+Q"-@.:V>E() 3BLI13-Z=24=4>-^)O!NW<RQ_I7E>IZ9)93-D'
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2$XI:0C-
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MU<\U[%X8\,K;(C.G(]JTC$PQ6(C3B,\.>$5MT1F4?E7?6EFD$0 4<5-# D2
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4R$-8#M-/(>#5]4:X;G-:=KIP7#$4[#CIJ9=GHPE(>1>:Z""T2)  .E.&(^
M*F!R*+!*I?8 ,48I:*" IM.HH%8****!A1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:UM50<BK@  H& *7K3,V[C2 32BBC%,A"T444B@HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *C).ZI** "BFLV*4'(H 6BF&11U(H$@)X
M- #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-OD)!'%+#8JW)%58YU-HIV.GID$K6Q&BQ\ 4JQ",<4\#/-,;E<=C(IN#FG9
MI:"+A1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0G H#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MRFYNY306Z'+@9K8T^[A486O+[_Q'_IA2-\\^M=7X6EEO "V:VB%2*Y=3OXI
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M*.+$S6R) ,"BD)I0:LX+C<8.:<#FCK28Q3&V.HI,TM( HHHH **** "BBB@
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M2?!T407=$/RKI[?P];QJ/D'Y5TJ"/,EC$CQ"'P'.<9!K8M/A^XP67->S1:3
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M10 AI 3FES13"Z$).:=112 **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:/RK<5 .U/K>,$CBGB9RZE.&Q2(<**G'R\ 5+28J[&#DWN(I-.HHIDA1110
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M5[BT"DI10"%HHHI%!1110 E&*6B@5A#333Z0BF)H9TI:7% %!-@I:,48H*2
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MI$OFN-W$&G^82,8I",FE.,4"]X<'.,49 YIFX 4WF@&VR?@C.:C-(J,>]/\
M+)I$^\1Y-%2X"C!J/%,T284=:,<TX+FF,;2$5(2,8J/=BBPKKJ*!CFD/6I$&
M:;)'W%/EZF<IQ0TR<4WSJ6*!IWVJ#6U:>&+BY7@'FJY3EG62,,RXZ4GF$UU:
M^!;KJ0?RJQ%X%N<YP?RJE3.6>+2ZG%EI&Z U(L4S#A#7H5OX%ER,J?RK:L_!
M>W :/]*M4S'Z]'JSRF/3[E^D;?E5N#0KF5L>4WY5[;8^$(E W1#\JW+3PO;Q
ML"81^5:1I&-7,8<NYXI9>$)I""T9_*NKT[P1OVAD_2O6(]%MEQB(?E5Z*RAC
M'" 5LJ2/&GF$[Z,X2P\$0Q 94?E72V7A^*UP0HK=$:CH*6K4$CDGBIRZD$<2
MQC 45. /2C I:M(YV[A2 4M%,04F*6B@ HHHH *3%+10 F*6BB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 E+2$44"%HI*6@84444 %%%% "
M8YI:*3- 7%HI,TM 7$P*"HI:*5@N-VCTI1B@C- &*:2&+28I:*5A!24M(:&@
MN'!JO+;)(.15@"BDT.,FM3+?289.H%5)_#UM*,%1^5;]!%)11LJ\UU.(NO!M
MHYR$'Y4NG^%8;>;(3]*[38#VHV@=!2Y2WBI6L5;:RCA48%6\#&*3-(.:I'+*
MHVQXH-)TI0:H5[@*6BB@84444 %%%% !1110 4444 %%%% "8HQ2T4 &****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI*0
M"TA%+13 ;12XHIDV 4M)2TAH****!A1110 4444 %%%% !2&EHH 0"C%+10
MTBEQ2T4"L-I0*,4M 6"BBB@84444 %%%% !1110 4E+10 4444 (*4T4AH0M
MAIS2BC%+B@E+46BBB@L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *2EI*D!:*8<YIPZ50["T444""BBB@ HHHH **
M** "BBB@!*6DI:E %%%%4 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1129I:@+132X'>C>/44Q7'4
M4FX>HIGFKG&:=AW)**0$&EI %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 44F:,T!<6BBB@ HHHH **
M** "BBB@ HHHI7 ****8!1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%-+ 4 .HI-P]:3</6@5QU%-# TIH&!.* <T@'/-.IC"BBDW<TA"T444
M )FD#<TN129%))C'44FX4;A3$%+24M2MP"BBBJ **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *3-&:0NH[B@0ZBF>8I[BG"@+BT4F:6@84
M444 %%%% !1112 ***0L!3 6BF"1?44>8,XS3L XTM)UI:0!129I: "BBB@
MHHHH **** "BBBBX!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1124 +1110 4444 %%%% !132X%*&!HL%Q:*3(I<T %%%% !1110 44
M44 %%%% !1110 4444 %%%% !129I: "BBB@ HHHH **2EI7 ****8!1110
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M**#4@%% H/%4 4M(*,4M0"EHHIH HHHI@%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 57N9/+C+$]*EE?8N:XCQ/XC%
MG%(F_'%:4X.3T(E)(J>)?%B6<;@/@CWKQ#Q)XKGO+LJDIP3ZT[Q/KTEW*X5L
M\^M<DL9D.]^M>E3A9:&$I=2PY>7YG.<T8 7&*L64+W#! ,UV&C^$)KQE)B)4
M^U;-);F#NSB8;%[EL*IK>MO"LTL60AS]*]=T;X>P(%9X\?A76V_A.UBCP%'Y
M5A.M%,?)(^<;CPE=1]%/Y5D7.BSP9)!XKZHD\*6LBG*C\JYK6/ \#HVR/]**
M=>+T'RM'SBEO(IYS4XFEMOF5L5VWB/PS+8,VR/\ 2N"ODF#%,'-7.:L6HW.W
M\+>,GM)$C>0]?6O=O#7B!+^) &R2*^3+"TNVN$*J>M>W> WO(6CWJ0*XZC3-
MHJS/= <BEJG8RM)$"WI4\C,.E<EM36Y+14<9)'-*\JQCYC2L,0@[JD[51?4[
M=#\SBHCK%LWW9!5*#)YD:!;M2KFJ4=_;N?OC-6EF5Q\IH<6A\R):*A+[3STI
MAO(5ZL*7*PN6&%(H-0"^A/\ $*E657&5.:5AW)*80<TTL10&)I\H7)112#I4
M;SQI]XT@8_--SS59]0MQU<5'_:EL#]\5:BS)LOTZJ*ZI;'^,5*M]"_W6%)Q9
M::+)IF#FE5PW0TZH:*3$%(PXH)QS4+7<2\%J<8B;.+\7SR102;3CBOGO7];O
M8KF3$K#GUKZ*\4/;2VTF6&<5\[>*+>+[1(1ZUZ%&FW$YI/WC.TWQ#>M<J#*W
M7UKW#P%>SW!7<Q->!Z7"GVQ,],U[]\/S;QA/F'2KG2M&Y%U?0]7M\^6,U-FJ
ML5U#C 85.)4;H:\Z2=SJB]!]-(-*3@9%-1MU18M,<0<4*#3J:SA>M4 M+59[
MZ&/[S 5 =6MNSBGRMDMI%UP2.*$R!S5!-6MV;&\5.M_;L<!Q1R,+ENBF)*K]
M#3J5AW$8&F!6S4E&X4K#N+1137=4&2: $8$GBG#I5<WL(ZL*%OH7. PS3LPN
M6" : *:'#=*1I%098T6%=#S1FJ;ZC K8+BI8KJ*4_*V:+,298HI#TIJDYHL4
M/HHHJ; %,E&8V^E/J.0_NV^E-"9YIXX0_99#7SYK,3/=''K7T'XX)^RR>E>
MZL2+DD>M>G05SGJ.Q EFS0C%5I+=D.#6A:7&X!:CO =V:]%05CBYG>Q'9!HI
M WO7L'@?5]@CC+5XUO=>M=/X8U-XKZ)<\9K"K3T-8MWU/JBRF$MNA'<59QS7
M.>'+X3VD8SDXKH\UXU2/+*QV1=T.HI :BG?9&34)79I?0Y_Q+=^3 ^#CBOG;
MQ;J+S7LB;N]>O>-]6\N-@&[5X)JUQYU^S9[UZ5"D<E2;:*$4+%^:O26I\G-1
M1L!4SRN4QVKUJ44EH<7.VS+>T9GR*[+P9;%;Q?K7+EW!KI_"4["]7'K6=>*L
M=5.3/H[PPNVT7Z5T-<WX4<O9J3Z5TE?/5?C9VQV"BF$G=3ATK.Q0C'M2*#2.
MZ)R35=]2MX_O.!56871<HJ@=6M0,[Q^=+'JMM(<*X-'*Q71=S1BF)(CC*FG,
MP7K2L%QU%5VNXEZM2"^A/1A1RL+HLTTMS34E1^AI2O-%NX7'T4T'%1O<QH<%
MJ5@NB4T57-] .K"G)<QR?=.:?*Q7)34>UMV:?[U&]U'%]YL5/*%[DH%-D&Y<
M55_M.W+8#BK2.'7<#5+0#R_QWH4UX'90:\&U/PW<PW;DJ>OI7U]>V<5Q&P<#
MI7'W7A.PN9F+ <GTKLIS31#/FBRT.=KQ!M/7TKW3P)H3P^6Q6MV+P/81S*RJ
M./:NLT[3HK-5" <4YR5KF;+]M&8D JPWW33,@#)J)[R)5.6KD=VS6+2/._'%
MY+;P2E6( KP:^\2W(N'"RGKZU[AXYEBFMY0#G(KY_P!1LE^T.5]:]&E3ND8.
M:OJ:FD:_=2WB@R'KZU[QX'DFN(E+,3Q7SYH=LJ7BD^M?0G@2XABA4%ATIUJ3
MC&XHS3=D>BQ A,&I<562\A(X85,LBO\ =->8T[G4GH9.N6AN+8JHYQ7@WC7P
MY.T[$*?RKZ.D0.N#7/:KHEI=9\P#-:TI)&4T?)C:-<QSG@]:Z?PUX9NIKZ*7
M!P#Z5[&_@S3WE)*CKZ5OZ3X;L[4+L XKIJ/W2(N[+7ANQ:UM(PPZ"NCXJ%(Q
M$@"]J4%LUQ/4Z+V)<4'@4QIEC'S'%1M>0XY85(61,K9IU5DNH2?E:I\AAD4-
M!<=3,'-&X+UJ%[^"+[S 4TGT!.Y9YI:S_P"V+7/^L%2IJ-O)]UQ1RL$T6Z*C
M696'!IV:FP[CJ0TTL%&34+7L*]6%-)A=$QS0H-5&U2V7JXI%U:U8X#BG9B32
M+F#FG 5"EU')]ULU,"#4VL5>XA%)@XI6/'%(I/>@=R)4??GM4V<#FES36YID
M-C1,"<5(.14(B"G--:[BBX9L4VNPE+4F+;:<#D52;4;8]7%*NHVP'WQ1RNP[
MEVDS50:C W1Q4RS(XX-+E8-DN:*9S3=Q!HL)2'$'-/'2D4YIU#*04444AC2*
M!3J2A": ]*X?QPA-J?I7<5QGC;_CU/TK6E\1$WH?-_B*%OMK?6L-(QO%=#XD
M)^V-]:Y]=Q<8]:]:FD<S9W_@V)?M4?%?0>@KM@7Z5\_^#5?[5&<=Z^@=")\A
M<^E<>+5F:TW=FY2&BHY)ECZFN&QNV2TF:K?;H>FX4OVN(G&ZBS"Y9III%;=R
M*&( R:+"O="YS2U5:]A0\L*C;5;8=7%/E8KE[-,P=U4UU.W8_?%6([N)_NM0
MXM#4KEBBHV8]J12W>E8=R6FY!.*7M4?(:I*). *:9!3@<BF[!30AP.:6H'N(
MX?O'%0MJ=L/XQ5<K8FRYFFMSTK/;5(,\.,4L>K6Y/WQ3Y&M25*Y?4&GU72[B
MD^ZV:FSFI:8[H=124M(I!1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1137.U2: ,_5[D06Y8G'%> ^/M99KEE
M5CU]:]6\8ZGY=HP!YQ7S]XBO//G;<<G-=]"#2.>I)'/-*9)22<Y-68$,KA .
MM4ONMFNK\,Z6;NYC;&1FNU:(YF[G1^#_  HUQ,K,O6O;M$T**S@4%!D>U9WA
MC1TMH8SLQQ791J%&!7#B*SV1M2C=ZD>U8Q@**<N#4A (J+:=U<,I:'3RCR!B
MHG57X*BIJ0K1"3&XHY#Q'H"7B-A!S[5Y;?\ @!FNF8)U/I7OC1JW##-1-IUN
M_)05M[72Q/(>0Z%\/5.UF3I[5Z%IGAB.S1< #%=#%:Q0CY5Q4U0YW'8B@B\E
M<5*<#K1FLW5;];.$L3VHBG)V%=(EO-1BM4)+ 8KA]=\:1PA@'''O7)>+?%S*
M[JDF/QKRK4=>N+F1OWAZ^M=4:%M3GE4;V.]U3X@.'8*QK,@^(<RMRS5P)E>7
M[QS4D<>>U="A;<SY['IEI\1W$@RQKT#PYXYCNU&]P/J:^>'M90NY0:?::M=V
M#C#L #1*"EH4I'U+J/B.*.S\Q7'3UKS36OB(UK,55N]<4/%\LUH(FD)./6N:
MU*X:X?<3FH]C;8'-]3U&S^)#RL 2:]+\+^(/[0A!)ZU\OV;,)!@]Z]P^'LC_
M &=,FL*E.Q2FF>P#YT!I1A1S3+=LP+]*H:KJ*6D#DGH*YE=Z&[:2N)J>L)8H
M3N%<'K/C98E8AQQ[US'B[QB/G57Z>]>7W^MS73G#D@UU4Z)$IZ'>W7Q(?S&
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MG-?--O+-)>H6R>:]V^')R\>1Z5DVBD>T0/O3-2U#!@1C%2!LU@S9!NYQ3J3
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M(H][$YKT.,Y0&N2<;,V@[CJ***@L**** "BBB@ HHHH **** "BBB@ HHHH
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M<UCZ"\%N1;*/:O0(N4%<+X/0-;J5]*[J,805Y6(M<Z:4;(?2 4M%<QL%%%%
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M^5>A:%X%6$J60?E6<ZRL5&#.5\'^!PX1Y(_TKV32=#BL85V@9 JSINDQV48
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MJ7-,C&Q M.QDU@;*PZBBBD 4444 %%%% !1110 4444 %%%% !1110 4444
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MP:R;K1H;C[R UM8I:N,FB;7.9_X1BU/6(?E5JUT.W@/RQ@5N8HQ5^T8<I#'
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444K %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
..**** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
